Not applicable.
The present disclosure generally relates to two-dimensional materials, and, more specifically, to processes for perforating two-dimensional materials.
Graphene represents a form of carbon in which the carbon atoms reside within a single atomically thin sheet or a few layered sheets (e.g., about 20 or less) of fused six-membered rings forming an extended planar lattice. In its various forms, graphene has garnered widespread interest for use in a number of applications, primarily due to its favorable combination of high electrical and thermal conductivity values, good in-plane mechanical strength, and unique optical and electronic properties. In many aspects, the properties of graphene parallel those of carbon nanotubes, since both nanomaterials are based upon an extended sp2-hybridized carbon framework. Other two-dimensional materials having a thickness of a few nanometers or less and an extended planar lattice are also of interest for various applications. In an embodiment, a two dimensional material has a thickness of 0.3 to 1.2 nm. In other embodiment, a two dimensional material has a thickness of 0.3 to 3 nm.
Because of its extended planar structure, graphene offers several features that are not shared with carbon nanotubes. Of particular interest to industry are large-area graphene films for applications such as, for example, special barrier layers, coatings, large area conductive elements (e.g., RF radiators or antennas), integrated circuits, transparent electrodes, solar cells, gas barriers, flexible electronics and the like. In addition, graphene films can be produced in bulk much more inexpensively at the present time than can carbon nanotubes.
Some envisioned applications for graphene and other two-dimensional materials are predicated upon forming a plurality of nanometer-scale holes in the planar structure of these nanomaterials. The process of forming holes in graphene and other two-dimensional materials will be referred to herein as “perforation,” and such nanomaterials will be referred to herein as being “perforated.” In a graphene sheet an interstitial aperture is formed by each six carbon atom ring structure in the sheet and this interstitial aperture is less than one nanometer across. In particular, this interstitial aperture is believed to be about 0.3 nanometers across its longest dimension (the center to center distance between carbon atoms being about 0.28 nm and the aperture being somewhat smaller than this distance). Perforation of sheets comprising two-dimensional network structures typically refers to formation of holes larger than the interstitial apertures in the network structure.
Perforation of graphene and other two-dimensional materials can modify the electrical properties of the material and its resistance to flow of fluid through the material. For example, the hole density of perforated graphene can be used to tune the electrical conductivity of this nanomaterial and in some instances can be used to adjust its band gap. Filtration applications are another area where perforated graphene and other perforated two-dimensional materials have generated considerable interest. Due to the atomic-level thinness of graphene and other two-dimensional materials, it can be possible to achieve high liquid throughput fluxes during filtration processes, even with holes being present that are only single-nanometer in size.
High performance, high selectivity filtration applications are dependent upon a sufficient number of holes of a desired size being present in a filtration membrane. Although a number of processes are known for perforating graphene and other two-dimensional materials, production of holes with a desired size range, a narrow size distribution, and a high hole density remains a challenge. At least one of these parameters is often lacking in conventional perforation processes.
Chemical techniques can be used to create holes in graphene and other two-dimensional materials. Exposure of graphene or another two-dimensional material to ozone or an atmospheric pressure plasma (e.g., an oxygen/argon or nitrogen/argon plasma) can effect perforation, but the holes are often lacking in terms of their density and size distribution. In many instances, it can be difficult to separately control hole nucleation and hole growth, so these processes often yield broad distributions of hole sizes. Further, many chemical perforation techniques produce holes that are at the extremes of 1) low hole density and small hole size, and 2) high hole density and large hole size. Neither of these extremes is particularly desirable for filtration applications. The first extreme is undesirable in terms of throughput flux, and the second extreme is undesirable for selectively excluding impurities that are smaller than the hole size.
Physical techniques can also be used to remove matter from the planar structure of two-dimensional materials in order to create holes. Hyperthermal ion beams tend to make pores in graphene and other two-dimensional materials that are too small for effective filtration to occur, primarily because the interaction of graphene and other two-dimensional materials with ions at hyperthermal velocities can be rather poor. The hyperthermal energy regime is defined as being intermediate between the thermal and low energy regimes. For example, a hyperthermal energy regime includes the energy range between 1 eV and 500 eV. Focused ion beams, in contrast, tend to make holes that are too few in number. Due to their very high energy flux, focused ion beams can also be exceedingly damaging to many substrates upon which the two-dimensional material is disposed. Because of their high energy requirements and small beam size, it is also not considered practical to utilize focused ion beams for perforating a large dimensional area.
Nanomaterials perforated with holes in a size range of about 0.3 nm to about 10 nm with a high hole density and narrow hole size distribution can be particularly difficult to prepare. Holes within this size range can be particularly effective for various filtration applications including, for example, reverse osmosis, molecular filtration, ultrafiltration and nanofiltration processes. As an example, holes in the size range 0.3 nm to 0.5 nm may be used for some gas separation processes. Holes in the size range 0.7 nm to 1.2 nm may be used for some desalination processes.
In view of the foregoing, scalable processes for perforating graphene and other two-dimensional materials in order to produce holes with a high hole density, narrow size distribution and a small hole size would be of considerable interest in the art. In particular, scalable processes to produce holes having a size, hole density, and size distribution suited for various filtration applications would be of considerable interest in the art. The present disclosure satisfies the foregoing needs and provides related advantages as well.
In various embodiments, processes for perforating a two-dimensional material are described herein. In one aspect, exposure of a composite of a layer including the two-dimensional material and a layer of another material to a source of ions produces a plurality of holes in the two-dimensional material even when the energy and/or flux of the ions is relatively low. In an embodiment, the layer of the other material is not a layer or sheet of a two-dimensional material.
In some embodiments, the processes for perforation can include (1) exposing a two-dimensional material in contact with at least one layer of a material other than the two-dimensional material to an ion source and (2) interacting a plurality of ions from the ion source with the two-dimensional material and with the at least one layer. In an embodiment, the at least one layer is in continuous contact with the two-dimensional material while the two-dimensional material is being exposed to the ion source. In an embodiment, the ions introduce a plurality of defects in the two-dimensional material and an interaction of the ions with the at least one layer promotes expansion of the defects into a plurality of holes defined in the two-dimensional material. In embodiments, the ion source provides an ion energy ranging from 0.75 keV to 10 keV, from 1 keV to 10 keV, from 1 keV to 5 keV, from 2 keV to 10 keV, or from 5 keV to 10 keV. In embodiments, the ion source provides an ion dose ranging from 1×1010 ions/cm2 to 1×1017 ions/cm2, from 1×1011 ions/cm2 to 1×1015 ions/cm2, or from 1×1013 ions/cm2 to 1×1019 ions/cm2.
In an embodiment, the process comprises the steps of exposing a composite multilayered material to ions produced by an ion source, the multilayered material comprising a first layer comprising a two-dimensional first material and a second layer of a second material in contact with the first layer; and producing a plurality of holes in the two-dimensional first material by interacting a plurality of ions from the ion source, neutralized ions from the ion source or a combination thereof with the two-dimensional first material and with the second material. In an embodiment the ion source is a broad beam or flood source. As regards the neutralized ions, in some embodiments at least a portion of the ions originating from the ion source are neutralized as they interact with the multilayered material. For example, an ion may be neutralized either near the surface of a given layer or during collisions within the layer. In an embodiment, the first layer has a first side and a second side with the first side facing the ion source. The first side of the first layer may be termed the “frontside” of the first layer.
In an embodiment, the second layer is a “frontside layer” disposed on the first side of the first layer. During exposure of the multilayered material to the source of ions, at least a portion of the ions and/or neutralized ions interact with the material of the frontside layer, with a plurality of the ions and/or neutralized ions passing through the frontside layer before interacting with the layer comprising the two-dimensional material. In an embodiment, the frontside layer is removed after perforation. When the second layer is a “backside layer” disposed on the second side of the first layer, at least a portion of the ions and/or neutralized ions interact with the two-dimensional material of the first layer, with a plurality of ions and/or neutralized ions passing through the first layer before interacting with the backside layer. The multilayered material may further comprise a third layer of a third material. In an embodiment, the third layer is disposed on the opposite side of the first layer from the second layer, so that the first layer comprising the two-dimensional material contacts both frontside and backside layers of other materials.
In an embodiment, the second material is selected so that interaction of the ions and/or neutralized ions with the second material contributes to the perforation process. In an embodiment, the second material forms fragments upon interaction with the ions and/or neutralized ions. The type of fragments formed depends at least in part on the second material. The fragments may be atoms, ions or fragments of molecules (e.g. part of a polymer chain).
When the layer of the second material is a frontside layer, the thickness of the layer is thin enough to allow the ions and/or neutralized ions to penetrate to the layer comprising the two-dimensional material. In an embodiment, the average thickness of the layer of the second material is from 1 to 10 nm. Frontside layers may be continuous or discontinuous. In some embodiments, the at least one layer can be a layer such as, deposited silicon, a deposited polymer, a condensed gas or a condensed organic compound or any combination thereof. In embodiments, the polymer comprises the elements carbon and hydrogen and optionally further comprises one or more elements selected from the group consisting of silicon, oxygen, nitrogen, fluorine, chlorine and bromine. In embodiments, the polymer is a polycarbonate, a polyacrylate, a polyethylene oxide, an epoxide, a silicone, polytetrafluoroethylene (PTFE) or polyvinyl chloride (PVC). In an embodiment, the condensed gas is a noble gas such as xenon. In embodiments, the condensed organic compound is a mercaptan, an amine or an alcohol. In an embodiment, the organic compound comprises an alkyl group having 2 to 15, 2 to 10 or 5 to 15 carbon atoms.
When the layer of the second material is a backside layer, the layer may be thicker than the layer comprising the two-dimensional material. In an embodiment, the backside layer is 1 micrometer to 10 micrometers thick. In an additional embodiment the backside layer is 5 micrometers to 10 micrometers thick. In an embodiment, the layer provides a substrate for the layer of the two-dimensional material. In an embodiment, the backside layer is a growth substrate upon which the graphene or other two-dimensional material is grown. In an embodiment, the growth substrate is a metal growth substrate. In an embodiment, the metal growth substrate is a substantially continuous layer of metal rather than a grid or mesh. Metal growth substrates compatible with growth of graphene and graphene-based materials include transition metals and their alloys. In embodiments, the metal growth substrate is copper based or nickel based. In embodiments, the metal growth substrate is copper or nickel. In another embodiment, the backside layer can be a secondary substrate to which the graphene or other two-dimensional material has been transferred following growth.
In embodiments, the energy of the ions ranges from 0.01 keV to 10 keV, 0.5 keV to 10 keV, 0.75 keV to 10 keV, from 1 keV to 10 keV, from 1 keV to 5 keV, from 2 keV to 10 keV, or from 5 keV to 10 keV. In embodiments, ion energies greater than 0.75 keV or 1 keV are preferred when the two-dimensional material comprises a sheet of graphene-based material and further comprises at least some non-graphenic carbon-based material. In embodiments, the ion source provides an ion dose to the multilayered material ranging from 1×1010 ions/cm2 to 1×1017 ions/cm2, from 1×1011 ions/cm2 to 1×1015 ions/cm2 or from 1×1013 ions/cm2 to 1×1019 ions/cm2. In an embodiment, the ion dose is adjusted based on the ion, with lighter ions (lower mass ions) being provided at a higher dosage. In embodiments, the ion flux or beam current density ranges from 0.1 nA/mm2 to 100 nA/mm2, from 0.1 nA/mm2 to 10 nA/mm2, 0.1 nA/mm2 to 1 nA/mm2, from 1 nA/mm2 to 10 nA/mm2, or from 10 nA/mm2 to 100 nA/mm2.
In various embodiments, the two-dimensional material comprises a sheet of a graphene-based material. In an embodiment, the first layer comprises a sheet of a graphene-based material. In an embodiment, the sheet of graphene-based material is a sheet of single or multilayer graphene or a sheet comprising a plurality of interconnected single or multilayer graphene domains. In embodiments, the multilayer graphene domains have 2 to 5 layers or 2 to 10 layers. In an embodiment, the layer comprising the sheet of graphene-based material further comprises non-graphenic carbon-based material located on the surface of the sheet of graphene-based material. In an embodiment, the amount of non-graphenic carbon-based material is less than the amount of graphene. In embodiments, the amount of graphene in the graphene-based material is from 60% to 95% or from 75% to 100%.
In embodiments, the characteristic size of the perforation is from 0.3 to 10 nm, from 0.3 to 0.5 nm, from 0.4 to 10 nm, from 0.5 to 2.5 nm, from 0.5 to 10 nm, from 5 nm to 20 nm, from 0.7 nm to 1.2 nm, from 10 nm to 50 nm, from 50 nm to 100 nm from 50 nm to 150 nm, or from 100 nm to 200 nm. In an embodiment, the average pore size is within the specified range. In embodiments, 70% to 99%, 80% to 99%, 85% to 99% or 90 to 99% of the perforations fall within a specified range, but other pores fall outside the specified range. If the pores falling outside the specified range are larger than specified in the range, these pores may be termed “non-selective.”
In more specific embodiments, the processes can include providing a sheet of a graphene-based material on a metal growth substrate, exposing the sheet of a graphene-based material to an ion source providing an ion dose ranging from 1×1010 ions/cm2 to 1×1017 ions/cm2, from 1×1011 ions/cm2 to 1×1015 ions/cm2 or from 1×1013 ions/cm2 to 1×1019 ions/cm2 and having an ion energy ranging from 0.75 keV to 10 keV, from 1 keV to 10 keV, from 1 keV to 5 keV, from 2 keV to 10 keV, or from 5 keV to 10 keV, interacting a plurality of ions and/or neutralized ions from the ion source with the graphene and with the metal growth substrate, in which the ions introduce a plurality of defects in the graphene and an interaction of the ions and/or neutralized ions with the metal growth substrate ejects toward the graphene a plurality of layer fragment from the metal growth substrate, and expanding the defects in the graphene with the layer fragments to define a plurality of holes in the graphene. The metal growth substrate is disposed on a side of the graphene opposite the ion source and constitutes a backside layer. In an embodiment when the layer is a metal growth substrate, the layer fragments constitute metal atoms or metal ions.
In other more specific embodiments, the processes includes exposing a sheet of a graphene-based material having thereon a frontside layer to an ion source providing an ion dose ranging from 1×1010 ions/cm2 to 1×1017 ions/cm2, from 1×1011 ions/cm2 to 1×1015 ions/cm2 or from 1×1013 ions/cm2 to 1×1019 ions/cm2 and having an ion energy ranging from 0.75 keV to 10 keV, from 1 keV to 10 keV, from 1 keV to 5 keV, from 2 keV to 10 keV, or from 5 keV to 10 keV, interacting a plurality of ions and/or neutralized ions from the ion source with the graphene and with the frontside layer to introduce a plurality of defects in the graphene. In an embodiment, interaction of the ions and/or neutralized ions with the frontside layer ejects toward the graphene a plurality of layer fragments, and expanding the defects in the graphene with the layer fragments to define a plurality of holes in the graphene. The frontside layer is disposed on the same side of the graphene as the ion source.
In still other more specific embodiments, the processes can include exposing a sheet of a graphene-based material present on a backside layer to an ion source providing an ion dose ranging from 1×1010 ions/cm2 to 1×1017 ions/cm2, from 1×1011 ions/cm2 to 1×1015 ions/cm2 or from 1×1013 ions/cm2 to 1×1019 ions/cm2 and having an ion energy ranging from 0.75 keV to 10 keV, from 1 keV to 10 keV, from 1 keV to 5 keV, from 2 keV to 10 keV, or from 5 keV to 10 keV, and interacting a plurality of ions and/or neutralized ions from the ion source with the graphene and with the backside layer to introduce a plurality of defects in the graphene. The backside layer is located on a side of the graphene opposite the ion source. In an embodiment, the backside layer disperses an impact energy of the ions and/or neutralized ions with the backside layer into an area of the graphene surrounding the defects created upon interacting the ions and/or neutralized ions with the graphene and promotes expansion of the defects into holes.
The foregoing has outlined rather broadly the features of the present disclosure in order that the detailed description that follows can be better understood. Additional features and advantages of the disclosure will be described hereinafter. These and other advantages and features will become more apparent from the description below taken in conjunction with the drawings.
For a more complete understanding of the present disclosure, and the advantages thereof, reference is now made to the following descriptions to be taken in conjunction with the accompanying drawings describing specific embodiments of the disclosure, wherein:
The present disclosure is directed, in part, to various processes for producing a plurality of holes in graphene, graphene-based materials and other two-dimensional materials. In an embodiment, the first layer comprises a sheet of graphene-based material. Graphene-based materials include, but are not limited to, single layer graphene, multilayer graphene or interconnected single or multilayer graphene domains and combinations thereof. In an embodiment, graphene-based materials also include materials which have been formed by stacking single or multilayer graphene sheets. In embodiments, multilayer graphene includes 2 to 20 layers, 2 to 10 layers or 2 to 5 layers. In embodiments, graphene is the dominant material in a graphene-based material. For example, a graphene-based material comprises at least 30% graphene, or at least 40% graphene, or at least 50% graphene, or at least 60% graphene, or at least 70% graphene, or at least 80% graphene, or at least 90% graphene, or at least 95% graphene. In embodiments, a graphene-based material comprises a range of graphene selected from 30% to 95%, or from 40% to 80% from 50% to 70%, from 60% to 95% or from 75% to 100%.
As used herein, a “domain” refers to a region of a material where atoms are uniformly ordered into a crystal lattice. A domain is uniform within its boundaries, but different from a neighboring region. For example, a single crystalline material has a single domain of ordered atoms. In an embodiment, at least some of the graphene domains are nanocrystals, having domain size from 1 to 100 nm or 10-100 nm. In an embodiment, at least some of the graphene domains have a domain size greater than 100 nm to 1 micron, or from 200 nm to 800 nm, or from 300 nm to 500 nm. “Grain boundaries” formed by crystallographic defects at edges of each domain differentiate between neighboring crystal lattices. In some embodiments, a first crystal lattice may be rotated relative to a second crystal lattice, by rotation about an axis perpendicular to the plane of a sheet, such that the two lattices differ in “crystal lattice orientation”.
In an embodiment, the sheet of graphene-based material comprises a sheet of single or multilayer graphene or a combination thereof. In an embodiment, the sheet of graphene-based material is a sheet of single or multilayer graphene or a combination thereof. In another embodiment, the sheet of graphene-based material is a sheet comprising a plurality of interconnected single or multilayer graphene domains. In an embodiment, the interconnected domains are covalently bonded together to form the sheet. When the domains in a sheet differ in crystal lattice orientation, the sheet is polycrystalline.
In embodiments, the thickness of the sheet of graphene-based material is from 0.34 to 10 nm, from 0.34 to 5 nm, or from 0.34 to 3 nm. In an embodiment, a sheet of graphene-based material comprises intrinsic defects. Intrinsic defects are those resulting from preparation of the graphene-based material in contrast to perforations which are selectively introduced into a sheet of graphene-based material or a sheet of graphene. Such intrinsic defects include, but are not limited to, lattice anomalies, pores, tears, cracks or wrinkles. Lattice anomalies can include, but are not limited to, carbon rings with other than 6 members (e.g. 5, 7 or 9 membered rings), vacancies, interstitial defects (including incorporation of non-carbon atoms in the lattice), and grain boundaries.
In an embodiment, the layer comprising the sheet of graphene-based material further comprises non-graphenic carbon-based material located on the surface of the sheet of graphene-based material. In an embodiment, the non-graphenic carbon-based material does not possess long range order and may be classified as amorphous. In embodiments, the non-graphenic carbon-based material further comprises elements other than carbon and/or hydrocarbons. Non-carbon elements which may be incorporated in the non-graphenic carbon include, but are not limited to, hydrogen, oxygen, silicon, copper and iron. In embodiments, the non-graphenic carbon-based material comprises hydrocarbons. In embodiments, carbon is the dominant material in non-graphenic carbon-based material. For example, a non-graphenic carbon-based material comprises at least 30% carbon, or at least 40% carbon, or at least 50% carbon, or at least 60% carbon, or at least 70% carbon, or at least 80% carbon, or at least 90% carbon, or at least 95% carbon. In embodiments, a non-graphenic carbon-based material comprises a range of carbon selected from 30% to 95%, or from 40% to 80%, or from 50% to 70%.
Such nanomaterials in which pores are intentionally created will be referred to herein as “perforated graphene”, “perforated graphene-based materials” or “perforated two-dimensional materials.” The present disclosure is also directed, in part, to perforated graphene, perforated graphene-based materials and other perforated two-dimensional materials containing a plurality of holes ranging from about 0.3 nm to about 10 nm in size. The present disclosure is further directed, in part, to perforated graphene, perforated graphene-based materials and other perforated two-dimensional materials containing a plurality of holes ranging from about 0.3 nm to about 10 nm in size and having a narrow size distribution, including but not limited to a 1-10% deviation in size or a 1-20% deviation in size. In an embodiment, the characteristic dimension of the holes is from 0.5 nm to 10 nm. For circular holes, the characteristic dimension is the diameter of the hole. In embodiments relevant to non-circular pores, the characteristic dimension can be taken as the largest distance spanning the hole, the smallest distance spanning the hole, the average of the largest and smallest distance spanning the hole, or an equivalent diameter based on the in-plane area of the pore. As used herein, perforated graphene-based materials include materials in which non-carbon atoms have been incorporated at the edges of the pores
As discussed above, conventional processes for perforating graphene and other two-dimensional materials with a plurality of holes can be limited in terms of the obtained hole density, hole size and size distribution. Perforated nanomaterials having small holes with an effective size of about 10 nm or less can be particularly difficult to produce with a sufficient hole density and size distribution to support many intended applications. Filtration applications, for example, can be significantly impacted by an inability to produce holes of a selective size and hole density, as selectivity and throughput flux can be severely impacted. Moreover, presently available techniques for perforating graphene and other two-dimensional materials are not believed to be scalable to large dimensional areas (e.g., one to tens of square centimeters or more) in order to support commercial production efforts.
Current methods for perforating graphene and other two-dimensional materials include both chemical and physical processes. Chemical processes generally involve both hole nucleation and hole growth stages. However, hole nucleation and hole growth are usually difficult to separate from one another, thereby leading to a broad distribution of hole sizes. Physical processes generally involve a brute force knockout of atoms from the planar structure of the two-dimensional material. However, physical processes are rather energy inefficient, especially when considering their scaleup for commercial production efforts. Moreover, high energy ions can actually interact rather poorly with graphene and other two-dimensional materials, leading to a poor yield of atoms ejected during the knockout process.
In an embodiment, energetic ion perforation processes for graphene, graphene-based materials and other two-dimensional materials can be significantly enhanced by conducting the perforation process with at least one layer of a second material in continuous contact with the graphene or other two-dimensional material during its exposure to a broad field or flood ion source. A broad field or flood ion source can provide an ion flux which is significantly reduced compared to a focused ion beam. In an embodiment, the ion flux is from 0.1 nA/mm2 to 100 nA/mm2. By utilizing a broad ion field in conjunction with at least one layer in continuous contact with the graphene or other two-dimensional material, significantly improved perforation can be obtained in the form of small hole sizes, narrow size distributions, and high hole densities. In an embodiment, the hole density is characterized by the spacing between the holes. In an embodiment where the average pore size is from 0.5 nm to 2.5 nm, the average spacing between the pores is from 0.5 nm to 5 nm. The processes of the present disclosure are readily distinguished from focused ion beam processes, which have higher ion fluxes and/or ion energies. The broad ion field processes of the present disclosure are considerably more scalable in terms of areal coverage for commercial processing. Depending on their location, the layer(s) in continuous contact with the graphene or other two-dimensional material can impact the perforation process in several different ways, as discussed hereinafter.
In embodiments, the energetic ion perforation processes described herein utilize the knockout approach of physical perforation processes while also facilitating a discrete hole growth stage, like chemical processes. Unlike conventional chemical and physical perforation processes, however, the perforation processes of the present disclosure advantageously separate the hole nucleation and growth stages from one another while still allowing nucleation and growth to occur in a highly concerted fashion. In embodiments, the one or more layers in continuous contact with the graphene or other two-dimensional material allow highly concerted nucleation and growth to occur. Specifically, the one or more layers allow hole nucleation to be followed in short order by hole growth as a result of a single incident ion impact with the graphene or other two-dimensional material In conventional processes, hole nucleation and growth are not concerted. Because the hole nucleation and growth are separated but concerted stages in the processes of the present disclosure, a narrow hole size distribution can be obtained. Moreover, the processes of the present disclosure are advantageously suited to produce holes that are about 10 nm in size or under, which can be desirable for a number of applications, including filtration. Further, the hole size and/or hole density can be adjusted to suit the needs of a particular application. In an embodiment, a higher fluence or exposure time increases the number of holes (until the holes begin to overlap). Higher ion energies can either increase or decrease the hole size depending on the details of the interaction. The hole density can be modulated by adjusting the exposure time of the graphene or other two-dimensional material to the ion source.
Thus, the processes of the present disclosure are capable of providing all three of the key needs for perforated graphene, graphene-based materials and other two-dimensional materials (small hole size, narrow size distribution, and high hole density). Moreover, because they make use of a broad ion field for affecting perforation, the processes of the present disclosure are advantageously scalable to large dimensional areas and can support commercial processing efforts.
As indicated above, the broad ion field used to affect perforation in embodiments of the processes of the present disclosure provides ions with an ion energy ranging between about 0.75 keV and about 10 keV. In an embodiment the ion energy ranges from 1 keV to 10 keV. In an additional embodiment the ion energy ranges from 1 keV to 5 keV. In a further embodiment the ion energy ranges from 2 keV to 10 keV. In an additional embodiment the ion energy ranges from 5 keV to 10 keV. Some ions having energies within this range may interact poorly with graphene and other two-dimensional materials, producing only point defects in the planar structure in the form of 1-2 knocked out atoms per incident ion (single-vacancies and di-vacancies). In an embodiment, the holes produced by the processes of the present disclosure produce holes larger in size than such a point defect. The processes of the present disclosure, specifically the layer(s) in continuous contact with the graphene or other two-dimensional material, can produce holes larger in size than would be predicted on the basis of the ion energy alone. Without wishing to be bound by any particular belief, contact of the frontside or backside layer with the two-dimensional material during ion irradiation is believed to advantageously promote expansion of the defects into holes of meaningful size through converting the high energy incident ions into a thermal bombardment of the graphene or other two-dimensional material. Layers in different locations with respect to the ion source can facilitate this effect in several ways through bond energy mismatch, as discussed further herein below.
Although certain embodiments are described herein with graphene as the two-dimensional material, it is to be recognized that other two-dimensional materials can be used similarly in alternative embodiments unless otherwise specified herein. Thus, considerable flexibility can be realized by practicing the disclosure in order to produce a particular perforated two-dimensional material having a desired set of properties.
In various embodiments, processes described herein can include exposing a two-dimensional material in continuous contact with at least one layer to an ion source, and interacting a plurality of ions and/or neutralized ions from the ion source with the two-dimensional material and with the at least one layer. In embodiments, the ions and/or neutralized ions introduce a plurality of defects in the two-dimensional material and an interaction of the ions and/or neutralized ions with the at least one layer promotes expansion of the defects into a plurality of holes defined in the two-dimensional material. The at least one layer is in continuous contact with the two-dimensional material while the two-dimensional material is being exposed to the ion source.
In various embodiments, the two-dimensional material comprises graphene, molybdenum sulfide, or boron nitride. In more particular embodiments, the two-dimensional material can be graphene. Graphene according to the embodiments of the present disclosure can include single-layer graphene, multi-layer graphene, or any combination thereof. Other nanomaterials having an extended two-dimensional molecular structure can also constitute the two-dimensional material in the various embodiments of the present disclosure. For example, molybdenum sulfide is a representative chalcogenide having a two-dimensional molecular structure, and other various chalcogenides can constitute the two-dimensional material in the embodiments of the present disclosure. Choice of a suitable two-dimensional material for a particular application can be determined by a number of factors, including the chemical and physical environment into which the graphene or other two-dimensional material is to be terminally deployed.
In various embodiments of the present disclosure, the holes produced in the graphene or other two-dimensional material can range from about 0.3 nm to about 10 nm in size. In a more specific embodiment, the holes can range from about 0.5 nm to about 2.5 nm in size. In an additional embodiment, the hole size is from 0.3 to 0.5 nm. In a further embodiment, the hole size is from 0.5 to 10 nm. In an additional embodiment, the hole size is from 5 nm to 20 nm. In a further embodiment, the hole size is from 0.7 nm to 1.2 nm. In an additional embodiment, the hole size is from 10 nm to 50 nm. In embodiments where larger hole sizes are preferred, the hole size is from 50 nm to 100 nm, from 50 nm to 150 nm, or from 100 nm to 200 nm. Holes within these size ranges can be particularly desirable for filtration applications. The 0.5 nm to 2.5 nm size range can be particularly effective for use in reverse osmosis filtration applications.
Contact times for the graphene or other two-dimensional material with the ion source can range between about 0.1 seconds and about 120 second in order to produce an ion fluence sufficient to produce these hole densities. Longer contact times can be used if desired in order to modulate the number of holes obtained in the planar structure.
The ion source inducing perforation of the graphene or other two-dimensional material in the embodiments of the present disclosure is considered to provide a broad ion field, also commonly referred to as an ion flood source. In an embodiment, the ion flood source does not include focusing lenses. In embodiments, the ion source is operated at less than atmospheric pressure, such as at 10−3 to 10−5 torr or 10−4 to 10−6 torr. In an embodiment, the environment also contains background amounts (e.g. on the order of 10−5 torr) of oxygen (O2), nitrogen (N2) or carbon dioxide (CO2). As indicated above, in an embodiment the ion source provides an ion dose ranging from 1×1010 ions/cm2 to 1×1017 ions/cm2 and having an ion energy ranging from 0.75 keV to 10 keV. In more particular embodiments, the ion energy can range from 1 keV to 10 keV or from 5 keV to 10 keV. In some embodiments, the ion dose can range between about 1×1011 ions/cm2 and about 1×1015 ions/cm2, between about 1×1012 ions/cm2 and about 1×1014 ions/cm2, or from 1×1013 ions/cm2 to 1×1019 ions/cm2. In an embodiment, the ion dose ranges from 1×1010 ions/cm2 to 1×1017 ions/cm2. In an additional embodiment the ion does ranges from 1×1011 ions/cm2 to 1×1015 ions/cm2. In a further embodiment, the ion dose ranges from 1×1013 ions/cm2 to 1×1019 ions/cm2. In an embodiment, the flux or beam current density is from 10 nA/nm2 to 100 nA/nm2. In embodiments, the ion beam may be perpendicular to the surface of the layers of the multilayered material (incidence angle of 0 degrees) or the incidence angle may be from 0 to 45 degrees, 0 to 20 degrees, 0 to 15 degrees or 0 to 10 degrees.
The ion source can provide any of a variety of ions suitable for inducing perforations in graphene, graphene-based materials and other two-dimensional materials. In an embodiment, the ion is singly charged. In another embodiment, the ion is multiply charged. In an embodiment, the ion is a noble gas ion (ion of an element from Group 18 of the periodic table). In an embodiment, the ion is other than a helium ion. In an embodiment the ion is an organic ion or organometallic ion. In an embodiment, the organic or organometallic ion has an aromatic component. In an embodiment, the molecular mass of the organic ion or organometallic ion is from 75 to 200 or 90 to 200. In illustrative embodiments, ions that can be supplied from the ion source to induce perforation of graphene or another two-dimensional material can include Xe+ ions, Ne+ ions, Ar+ ions, tropyllium ions (C7H7+) and ferrocenium ions [(C5H5)2Fe+]. In embodiments, when the ions are Xe+ ions, Ne+ ions, Ar+ ions, the dose is 1×1011 ions/cm2 to 1×1015 ions/cm2. In embodiments, when the ion comprises a plurality of elements (such as tropyllium and ferrocenium), the fluence is 1×1011 ions/cm2 to 1×1015 ions/cm2. In an embodiment, helium ions are provided with a dose from 1×1013 ions/cm2 to 1×1019 ions/cm2. The chosen ion and its energy can determine, at least in part, the size of the holes obtained in the graphene or other two dimensional material. In particular embodiments, the chosen ion and its energy can be chosen to eject fragments from the at least one layer toward the graphene or other two-dimensional material.
In an embodiment, the temperature of the multilayer composite is controlled during ion bombardment. In embodiment, the temperature is controlled from −130° C. to 200° C. or from −130° C. to 100° C. In an embodiment, the temperature may be selected to allow condensation of a gas on the frontside of the two-dimensional material. In an embodiment, where a metal backside layer is present, the temperature may be controlled from 50° C. to 80° C. The one or more layers in continuous contact with the graphene or other two-dimensional material can be a frontside layer or a backside layer, or both can be present. The term “frontside” refers to the condition of being on the same side of the two-dimensional material as the ion source. The term “backside” refers to the condition of being on the side of the two-dimensional material opposite the ion source. Depending on its location, the at least one layer can be natively or exogenously present on the graphene or other two-dimensional material, or the at least one layer can be intentionally deposited after formation of the graphene or other two dimensional material. For example, a metal growth substrate can constitute a backside layer in various embodiments of the present disclosure.
Generally, the at least one layer has a bond energy that is weaker than that of graphene or the two-dimensional material, which is characterized by strong bonds. That is, when the at least one layer is interacted with the ion source, bonds are broken in the at least one layer in preference to the graphene or other two-dimensional material due to a bond energy mismatch. In some embodiments, the at least one layer can be a deposited layer such as deposited silicon, a deposited polymer, or any combination thereof. If the graphene or other two-dimensional material remains on its metal growth substrate, a deposited layer can constitute a frontside layer. However, if the graphene or other two-dimensional material has been removed from its metal growth substrate, a deposited layer can constitute either a frontside layer or a backside layer. Deposited polymers that can include any polymer material that suitably adheres to the graphene-based material or other two-dimensional material such as silicone polymers, for example. In an embodiment, the deposited polymer does not completely delaminate from the graphene-based material during ion bombardment. Other suitable polymer layers can be envisioned by one having ordinary skill in the art.
In some embodiments, a frontside layer deposited on the graphene or other two-dimensional material can have a thickness ranging between about 1 nm and about 10 nm. Thicker frontside layers can also be present, if desired. Although the frontside layer can be deposited exogenously during synthesis of the graphene or other two-dimensional material, the frontside layer can also be deposited in a separate operation in other embodiments. For example, the frontside layer can be deposited by sputtering, spraying, spin coating, atomic layer deposition, molecular beam epitaxy or like techniques in some embodiments.
Various layers will now be further described according to their location and function.
In some embodiments, the at least one layer can be at least a frontside layer disposed on the same side of the two-dimensional material as the ion source. Illustrative frontside layers can include those described above. When a frontside layer is present, ions from the ion source interact with the frontside layer before interacting with the graphene or other two-dimensional material. As discussed hereinafter, this type of interaction can still promote the creation and expansion of holes in the planar structure of the graphene or other two-dimensional material by ejecting layer fragments from the frontside layer and impacting the layer fragments with the graphene or other two-dimensional material to form holes therein. Since the frontside layer is relatively thin, it has a low stopping power and allows the ions and/or neutralized ions to penetrate through the frontside layer to further interact with the graphene.
In an embodiment, ion bombardment of the frontside layer generates a plume of more, but lower energy particles, impinging on the graphene or other two dimensional material. In more specific embodiments, processes of the present disclosure can include ejecting toward the two-dimensional material a plurality of layer fragments from the frontside layer upon interaction of ions and/or neutralized ions therewith, and impacting the layer fragments with the two-dimensional material in an area of the two-dimensional material surrounding the defects created upon interacting the ions and/or neutralized ions with the two-dimensional material and promoting expansion of the defects into holes. Layer fragments can include atoms, ions, molecules or molecular fragments displaced from the frontside layer upon interaction of a high energy ion with the frontside layer. A frontside layer can be present in combination with a backside layer or a frontside layer can be present alone. Functions of the backside layer are discussed further below.
Without being bound by theory or mechanism, it is believed that hole definition or generation in the presence of a frontside layer can take place due to several synergistic effects. First, the graphene or other two-dimensional material can have an enhanced degree of chemical reactivity in the vicinity of the defects initially created by the high energy ions and/or neutralized ions. Second, the layer fragments from the frontside layer can turn a single impact event at the frontside layer into a plurality of impact events at the graphene or other two-dimensional material. Third, the layer fragments have a lower energy than do the incident high energy ions, thereby increasing the likelihood of successfully interacting with the graphene or other two-dimensional material in order to define a hole. Finally, because the frontside layer and the graphene or other two-dimensional material are in continuous contact with one another, the geometric spread of the layer fragments during their transit to the graphene or other two-dimensional material is minimal, thereby limiting the hole size. Thus, the combination of enhanced chemical reactivity in the vicinity of the defects and the more efficient interaction of the layer fragments with the graphene or other two-dimensional material can result in the definition of a hole.
As shown in
In some embodiments, the at least one layer in continuous contact with the graphene or other two dimensional material can be a backside layer disposed on a side of the graphene or other two-dimensional material opposite the ion source. In an embodiment, the backside layer is a metal growth substrate upon which the graphene or other two-dimensional material is grown, or the backside layer can be a secondary substrate to which the graphene or other two-dimensional material has been transferred following growth. In an embodiment, the secondary substrate is polymeric, including porous polymeric membranes. In either case, the backside layer can have a thickness that is significantly greater than that of the graphene or other two-dimensional material. Accordingly, the backside layer can have a much higher stopping power for the energetic ions and/or neutralized ions than does the graphene or other two-dimensional material. Upon stopping the energetic ions, the backside layer can disperse an impact energy of the ions and/or neutralized ions with the backside layer into an area of the graphene or other two-dimensional material surrounding the defects created upon interacting the ions with the two-dimensional material and promoting the expansion of the defects into holes. In more specific embodiments, a backside layer promotes expansion of defects in a two-dimensional material into holes in a manner somewhat similar to that described above for a frontside layer, in which fragments are directed towards the two-dimensional material. The backside layer may also promote formation of defects in the two-dimensional material. For example, even when an ion or neutralized ion does not form a hole when passing through the two-dimensional material, impact of the ions and/or neutralized ions with the backside layer may cause a small region in the backside layer to rapidly heat and expand, opening a hole in the graphene or other two-dimensional material.
Illustrative metal growth substrates upon which graphene, graphene-based materials and other two-dimensional materials can be grown and which can serve as the backside layer in the embodiments of the present disclosure include various metal surfaces containing a transition metal. In the case of graphene, for example, copper or nickel can be particularly effective for promoting epitaxial graphene growth. In some embodiments, the metal growth substrate can be formed substantially entirely of a metal, such as a metal foil or a metal sheet. In other embodiments, the metal growth substrate can include a metal surface on a different subsurface material. For example, a ceramic substrate having a metal surface can be used as the metal growth substrate and backside layer in various embodiments of the present disclosure.
Accordingly, in some embodiments, processes of the present disclosure can include ejecting toward the two-dimensional material, such as graphene, a plurality of layer fragments from the backside layer upon interaction of the ions and/or neutralized ions therewith, and impacting the layer fragments with the two-dimensional material in an area of the two-dimensional material surrounding the defects and promoting expansion of the defects into holes. That is, the backside layer can promote energy transfer to the graphene or other two-dimensional material in the form of layer fragments having thermal velocities in order to promote the creation of holes in the graphene or other two-dimensional material.
In some embodiments, both a frontside layer and a backside layer can be in continuous contact with the graphene or other two-dimensional material as it is interacted with the ions and/or neutralized ions from the ion source. The layer fragments generated from both the frontside layer and the backside layer can work in concert with one another to expand the generated defects in the graphene or other two-dimensional material into a plurality of holes. For example, in some embodiments, layer fragments generated from a suitable frontside layer and metal atoms or metal ions generated from a backside metal growth substrate can impact graphene from both sides of its planar structure to promote the creation of holes therein. This can be particularly effective for perforating multi-layer two-dimensional materials, such as multi-layer graphene, for example by holding the particles in a local region.
Accordingly, in embodiments where both a frontside layer and a backside layer are present, processes of the present disclosure can include ejecting toward the graphene or other two-dimensional material a plurality of layer fragments from the frontside layer upon interaction of the ions and/or neutralized ions therewith, ejecting toward the graphene or other two-dimensional material a plurality of layer fragments from the backside layer upon interaction of the ions and/or neutralized ions therewith, and impacting the layer fragments from both layers with the graphene or other two-dimensional material in an area surrounding the defects created upon interacting the ions and/or neutralized ions with the graphene or other two-dimensional material and promoting the expansion of the defects into holes.
In particular embodiments, processes of the present disclosure can include providing graphene on a metal growth substrate, exposing the graphene to an ion source, interacting a plurality of ions from the ion source with the graphene and with the metal growth substrate to introduce a plurality of defects in the graphene and an interaction of the ions and/or neutralized ions with the metal growth substrate ejecting toward the graphene a plurality of layer fragments including metal ions or metal atoms from the metal growth substrate, and expanding the defects in the graphene with the layer fragments to define a plurality of holes in the graphene. In an embodiment, the ion source provides to the graphene an ion dose ranging between about 1×1011 ions/cm2 and about 1×1017 ions/cm2 and having an ion energy ranging between about 0.75 keV and about 10 keV. The metal growth substrate is disposed on a side of the graphene opposite the ion source and constitutes a backside layer.
In some embodiments, the graphene can be coated with a frontside layer opposite the metal growth substrate that is disposed on the same side of the graphene as the ion source (see
In other particular embodiments, processes of the present disclosure can include exposing graphene to an ion source, the graphene having thereon a frontside layer disposed on the same side of the graphene as the ion source, interacting a plurality of ions and/or neutralized ions from the ion source with the graphene and with the frontside layer to introduce a plurality of defects in the graphene and an interaction of the ions and/or neutralized ions with the frontside layer ejecting toward the graphene a plurality of layer fragments, and expanding the defects in the graphene with the layer fragments to define a plurality of holes in the graphene. In an embodiment, the ion source provides to the graphene an ion dose ranging between about 1×1011 ions/cm2 and about 1×1017 ions/cm2 and having an ion energy ranging between about 0.75 keV and about 10 keV.
In still other particular embodiments, processes of the present disclosure can include exposing graphene to an ion source, the graphene being present on a backside layer located on a side of the graphene opposite the ion source, interacting a plurality of ions and/or neutralized ions from the ion source with the graphene and with the backside layer to introduce a plurality of defects in the graphene and an interaction of the ions and/or neutralized ions with the backside layer dispersing an impact energy of the ions and/or neutralized ions with the backside layer into an area of the graphene surrounding the defects created upon interacting the ions with the graphene an promoting expansion of the defects into holes. In an embodiment, the ion source provides to the graphene an ion dose ranging between about 1×1010 ions/cm2 and about 1×1017 ions/cm2 and having an ion energy ranging between about 0.75 keV and about 10 keV.
In more specific particular embodiments, processes of the present disclosure can include exposing graphene to an ion source, the graphene being present on a backside layer located on a side of the graphene opposite the ion source, interacting a plurality of ions and/or neutralized ions from the ion source with the graphene and with the backside layer to introduce a plurality of defects in the graphene and an interaction of the ions and/or neutralized ions with the backside layer ejecting toward the graphene a plurality of layer fragments, and expanding the defects in the graphene with the layer fragments to define a plurality of holes in the graphene. In an embodiment, the ion source provides to the graphene an ion dose ranging between about 1×1010 ions/cm2 and about 1×1017 ions/cm2 and having an ion energy ranging between about 0.75 keV and about 10 keV.
The perforated graphene, graphene-based materials and other two-dimensional materials described herein can be used in a variety of applications including filtration, electronics, barrier layers and films, gas barriers, and the like. Illustrative filtration applications in which the perforated graphene, graphene-based materials and other perforated two-dimensional materials can be used include, for example, reverse osmosis, molecular filtration, ultrafiltration and nanofiltration processes. When used in various filtration processes, the perforated graphene or other perforated two-dimensional material can be perforated and then transferred to a porous secondary substrate, where the perforated graphene or other perforated two-dimensional filtration serves as the active filtration membrane.
Although the invention has been described with reference to the disclosed embodiments, those skilled in the art will readily appreciate that these only illustrative of the invention. It should be understood that various modifications can be made without departing from the spirit of the invention. The invention can be modified to incorporate any number of variations, alterations, substitutions or equivalent arrangements not heretofore described, but which are commensurate with the spirit and scope of the invention. Additionally, while various embodiments of the invention have been described, it is to be understood that aspects of the invention may include only some of the described embodiments. Accordingly, the invention is not to be seen as limited by the foregoing description.
Every formulation or combination of components described or exemplified can be used to practice the invention, unless otherwise stated. Specific names of compounds are intended to be exemplary, as it is known that one of ordinary skill in the art can name the same compounds differently. When a compound is described herein such that a particular isomer or enantiomer of the compound is not specified, for example, in a formula or in a chemical name, that description is intended to include each isomers and enantiomer of the compound described individual or in any combination. One of ordinary skill in the art will appreciate that methods, device elements, starting materials and synthetic methods other than those specifically exemplified can be employed in the practice of the invention without resort to undue experimentation. All art-known functional equivalents, of any such methods, device elements, starting materials and synthetic methods are intended to be included in this invention. Whenever a range is given in the specification, for example, a temperature range, a time range, or a composition range, all intermediate ranges and subranges, as well as all individual values included in the ranges given are intended to be included in the disclosure. When a Markush group or other grouping is used herein, all individual members of the group and all combinations and subcombinations possible of the group are intended to be individually included in the disclosure.
As used herein, “comprising” is synonymous with “including,” “containing,” or “characterized by,” and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps. As used herein, “consisting of” excludes any element, step, or ingredient not specified in the claim element. As used herein, “consisting essentially of” does not exclude materials or steps that do not materially affect the basic and novel characteristics of the claim. Any recitation herein of the term “comprising”, particularly in a description of components of a composition or in a description of elements of a device, is understood to encompass those compositions and methods consisting essentially of and consisting of the recited components or elements. The invention illustratively described herein suitably may be practiced in the absence of any element or elements, limitation or limitations which is not specifically disclosed herein.
The terms and expressions which have been employed are used as terms of description and not of limitation, and there is no intention in the use of such terms and expressions of excluding any equivalents of the features shown and described or portions thereof, but it is recognized that various modifications are possible within the scope of the invention claimed. Thus, it should be understood that although the present invention has been specifically disclosed by preferred embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to by those skilled in the art, and that such modifications and variations are considered to be within the scope of this invention as defined by the appended claims.
In general the terms and phrases used herein have their art-recognized meaning, which can be found by reference to standard texts, journal references and contexts known to those skilled in the art. The preceding definitions are provided to clarify their specific use in the context of the invention.
All references throughout this application, for example patent documents including issued or granted patents or equivalents; patent application publications; and non-patent literature documents or other source material; are hereby incorporated by reference herein in their entireties, as though individually incorporated by reference, to the extent each reference is at least partially not inconsistent with the disclosure in this application (for example, a reference that is partially inconsistent is incorporated by reference except for the partially inconsistent portion of the reference).
All patents and publications mentioned in the specification are indicative of the levels of skill of those skilled in the art to which the invention pertains. References cited herein are incorporated by reference herein in their entirety to indicate the state of the art, in some cases as of their filing date, and it is intended that this information can be employed herein, if needed, to exclude (for example, to disclaim) specific embodiments that are in the prior art. For example, when a compound is claimed, it should be understood that compounds known in the prior art, including certain compounds disclosed in the references disclosed herein (particularly in referenced patent documents), are not intended to be included in the claim.
This application claims the benefit of priority under 35 U.S.C. §119 from U.S. Provisional Patent Applications 61/934,530, filed Jan. 31, 2014, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2187417 | Doble | Jan 1940 | A |
3024153 | Kennedy | Mar 1962 | A |
3303085 | Price et al. | Feb 1967 | A |
3501831 | Gordon | Mar 1970 | A |
3593854 | Swank | Jul 1971 | A |
3701433 | Krakauer et al. | Oct 1972 | A |
3802972 | Fleischer et al. | Apr 1974 | A |
4073732 | Lauer et al. | Feb 1978 | A |
4159954 | Gangemi | Jul 1979 | A |
4162220 | Servas | Jul 1979 | A |
4277344 | Cadotte | Jul 1981 | A |
4303530 | Shah et al. | Dec 1981 | A |
4743371 | Servas et al. | May 1988 | A |
4855058 | Holland et al. | Aug 1989 | A |
4880440 | Perrin | Nov 1989 | A |
4889626 | Browne | Dec 1989 | A |
4891134 | Vcelka | Jan 1990 | A |
4925560 | Sorrick | May 1990 | A |
4935207 | Stanbro et al. | Jun 1990 | A |
4976858 | Kadoya | Dec 1990 | A |
5052444 | Messerly et al. | Oct 1991 | A |
5080770 | Culkin | Jan 1992 | A |
5156628 | Kranz | Oct 1992 | A |
5182111 | Aebischer et al. | Jan 1993 | A |
5185086 | Kaali et al. | Feb 1993 | A |
5201767 | Caldarise et al. | Apr 1993 | A |
5244981 | Seidner et al. | Sep 1993 | A |
5314492 | Hamilton et al. | May 1994 | A |
5314960 | Spinelli et al. | May 1994 | A |
5314961 | Anton et al. | May 1994 | A |
5331067 | Seidner et al. | Jul 1994 | A |
5344454 | Clarke et al. | Sep 1994 | A |
5371147 | Spinelli et al. | Dec 1994 | A |
5425858 | Farmer | Jun 1995 | A |
5480449 | Hamilton et al. | Jan 1996 | A |
5514181 | Light et al. | May 1996 | A |
5516522 | Peyman et al. | May 1996 | A |
5549697 | Caldarise | Aug 1996 | A |
5562944 | Kafrawy | Oct 1996 | A |
5565210 | Rosenthal et al. | Oct 1996 | A |
5580530 | Kowatsch et al. | Dec 1996 | A |
5595621 | Light et al. | Jan 1997 | A |
5636437 | Kaschmitter et al. | Jun 1997 | A |
5639275 | Baetge et al. | Jun 1997 | A |
5641323 | Caldarise | Jun 1997 | A |
5658334 | Caldarise et al. | Aug 1997 | A |
5662158 | Caldarise | Sep 1997 | A |
5665118 | Lasalle et al. | Sep 1997 | A |
5671897 | Ogg et al. | Sep 1997 | A |
5679232 | Fedor et al. | Oct 1997 | A |
5679249 | Fendya et al. | Oct 1997 | A |
5687788 | Caldarise et al. | Nov 1997 | A |
5700477 | Rosenthal et al. | Dec 1997 | A |
5713410 | Lasalle et al. | Feb 1998 | A |
5716412 | Decarlo et al. | Feb 1998 | A |
5716414 | Caldarise | Feb 1998 | A |
5725586 | Sommerich | Mar 1998 | A |
5731360 | Pekala et al. | Mar 1998 | A |
5733503 | Kowatsch et al. | Mar 1998 | A |
5746272 | Mastrorio et al. | May 1998 | A |
5782286 | Sommerich | Jul 1998 | A |
5782289 | Mastrorio et al. | Jul 1998 | A |
5788916 | Caldarise | Aug 1998 | A |
5800828 | Dionne et al. | Sep 1998 | A |
5808312 | Fukuda | Sep 1998 | A |
5868727 | Barr et al. | Feb 1999 | A |
5897592 | Caldarise et al. | Apr 1999 | A |
5902762 | Mercuri et al. | May 1999 | A |
5906234 | Mastrorio et al. | May 1999 | A |
5910172 | Penenberg | Jun 1999 | A |
5910173 | Decarlo et al. | Jun 1999 | A |
5913998 | Butler et al. | Jun 1999 | A |
5925247 | Huebbel | Jul 1999 | A |
5932185 | Pekala et al. | Aug 1999 | A |
5935084 | Southworth | Aug 1999 | A |
5935172 | Ochoa et al. | Aug 1999 | A |
5954937 | Farmer | Sep 1999 | A |
5974973 | Tittgemeyer | Nov 1999 | A |
5976555 | Liu et al. | Nov 1999 | A |
5980718 | Van Konynenburg et al. | Nov 1999 | A |
6008431 | Caldarise et al. | Dec 1999 | A |
6013080 | Khalili | Jan 2000 | A |
6022509 | Matthews et al. | Feb 2000 | A |
6052608 | Young et al. | Apr 2000 | A |
6080393 | Liu et al. | Jun 2000 | A |
6093209 | Sanders | Jul 2000 | A |
6139585 | Li | Oct 2000 | A |
6152882 | Prutchi | Nov 2000 | A |
6156323 | Verdicchio et al. | Dec 2000 | A |
6193956 | Liu et al. | Feb 2001 | B1 |
6209621 | Treacy | Apr 2001 | B1 |
6213124 | Butterworth | Apr 2001 | B1 |
6228123 | Dezzani | May 2001 | B1 |
6264699 | Noiles et al. | Jul 2001 | B1 |
6292704 | Malonek et al. | Sep 2001 | B1 |
6309532 | Tran et al. | Oct 2001 | B1 |
6346187 | Tran et al. | Feb 2002 | B1 |
6375014 | Garcera et al. | Apr 2002 | B1 |
6426214 | Butler et al. | Jul 2002 | B1 |
6454095 | Brisebois et al. | Sep 2002 | B1 |
6455115 | Demeyer | Sep 2002 | B1 |
6461622 | Liu et al. | Oct 2002 | B2 |
6462935 | Shiue et al. | Oct 2002 | B1 |
6521865 | Jones et al. | Feb 2003 | B1 |
6532386 | Sun et al. | Mar 2003 | B2 |
6580598 | Shiue et al. | Jun 2003 | B2 |
6654229 | Yanagisawa et al. | Nov 2003 | B2 |
6659298 | Wong | Dec 2003 | B2 |
6660150 | Conlan et al. | Dec 2003 | B2 |
6661643 | Shiue et al. | Dec 2003 | B2 |
6692627 | Russell et al. | Feb 2004 | B1 |
6695880 | Roffman et al. | Feb 2004 | B1 |
6699684 | Ho et al. | Mar 2004 | B2 |
6719740 | Burnett et al. | Apr 2004 | B2 |
6905612 | Dorian et al. | Jun 2005 | B2 |
6924190 | Dennison | Aug 2005 | B2 |
7014829 | Yanagisawa et al. | Mar 2006 | B2 |
7071406 | Smalley et al. | Jul 2006 | B2 |
7092753 | Darvish et al. | Aug 2006 | B2 |
7138042 | Tran et al. | Nov 2006 | B2 |
7171263 | Darvish et al. | Jan 2007 | B2 |
7175783 | Curran | Feb 2007 | B2 |
7179419 | Lin et al. | Feb 2007 | B2 |
7190997 | Darvish et al. | Mar 2007 | B1 |
7267753 | Anex et al. | Sep 2007 | B2 |
7306768 | Chiga | Dec 2007 | B2 |
7357255 | Ginsberg et al. | Apr 2008 | B2 |
7374677 | McLaughlin et al. | May 2008 | B2 |
7381707 | Lin et al. | Jun 2008 | B2 |
7382601 | Yoshimitsu | Jun 2008 | B2 |
7434692 | Ginsberg et al. | Oct 2008 | B2 |
7452547 | Lambino et al. | Nov 2008 | B2 |
7459121 | Liang et al. | Dec 2008 | B2 |
7460907 | Darvish et al. | Dec 2008 | B1 |
7476222 | Sun et al. | Jan 2009 | B2 |
7477939 | Sun et al. | Jan 2009 | B2 |
7477940 | Sun et al. | Jan 2009 | B2 |
7477941 | Sun et al. | Jan 2009 | B2 |
7479133 | Sun et al. | Jan 2009 | B2 |
7505250 | Cho et al. | Mar 2009 | B2 |
7531094 | McLaughlin et al. | May 2009 | B2 |
7600567 | Christopher et al. | Oct 2009 | B2 |
7631764 | Ginsberg et al. | Dec 2009 | B2 |
7650805 | Nauseda et al. | Jan 2010 | B2 |
7674477 | Schmid et al. | Mar 2010 | B1 |
7706128 | Bourcier | Apr 2010 | B2 |
7761809 | Bukovec et al. | Jul 2010 | B2 |
7786086 | Reches et al. | Aug 2010 | B2 |
7866475 | Doskoczynski et al. | Jan 2011 | B2 |
7875293 | Shults et al. | Jan 2011 | B2 |
7935331 | Lin | May 2011 | B2 |
7935416 | Yang et al. | May 2011 | B2 |
7943167 | Kulkarni et al. | May 2011 | B2 |
7960708 | Wolfe et al. | Jun 2011 | B2 |
7998246 | Liu et al. | Aug 2011 | B2 |
8109893 | Lande | Feb 2012 | B2 |
8147599 | McAlister | Apr 2012 | B2 |
8262943 | Meng et al. | Sep 2012 | B2 |
8308702 | Batchvarova et al. | Nov 2012 | B2 |
8316865 | Ochs et al. | Nov 2012 | B2 |
8329476 | Pitkanen et al. | Dec 2012 | B2 |
8361321 | Stetson et al. | Jan 2013 | B2 |
8449504 | Carter et al. | May 2013 | B2 |
8475689 | Sun et al. | Jul 2013 | B2 |
8506807 | Lee et al. | Aug 2013 | B2 |
8512669 | Hauck | Aug 2013 | B2 |
8513324 | Scales et al. | Aug 2013 | B2 |
8535726 | Dai et al. | Sep 2013 | B2 |
8592291 | Shi et al. | Nov 2013 | B2 |
8617411 | Singh | Dec 2013 | B2 |
8666471 | Rogers et al. | Mar 2014 | B2 |
8686249 | Whitaker et al. | Apr 2014 | B1 |
8697230 | Ago et al. | Apr 2014 | B2 |
8698481 | Lieber et al. | Apr 2014 | B2 |
8715329 | Robinson et al. | May 2014 | B2 |
8721074 | Pugh et al. | May 2014 | B2 |
8734421 | Sun et al. | May 2014 | B2 |
8744567 | Fassih et al. | Jun 2014 | B2 |
8751015 | Frewin et al. | Jun 2014 | B2 |
8753468 | Caldwell et al. | Jun 2014 | B2 |
8759153 | Elian et al. | Jun 2014 | B2 |
8808257 | Pugh et al. | Aug 2014 | B2 |
8828211 | Garaj et al. | Sep 2014 | B2 |
8840552 | Brauker et al. | Sep 2014 | B2 |
8857983 | Pugh et al. | Oct 2014 | B2 |
8861821 | Osumi | Oct 2014 | B2 |
8894201 | Pugh et al. | Nov 2014 | B2 |
8940552 | Pugh et al. | Jan 2015 | B2 |
8950862 | Pugh et al. | Feb 2015 | B2 |
8974055 | Pugh et al. | Mar 2015 | B2 |
8975121 | Pugh et al. | Mar 2015 | B2 |
8979978 | Miller et al. | Mar 2015 | B2 |
8986932 | Turner et al. | Mar 2015 | B2 |
8993234 | Turner et al. | Mar 2015 | B2 |
8993327 | McKnight et al. | Mar 2015 | B2 |
9014639 | Pugh et al. | Apr 2015 | B2 |
9017937 | Turner et al. | Apr 2015 | B1 |
9023220 | Graphenea | May 2015 | B2 |
9028663 | Stetson et al. | May 2015 | B2 |
9035282 | Dimitrakopoulos et al. | May 2015 | B2 |
9045847 | Batchvarova et al. | Jun 2015 | B2 |
9050452 | Sun et al. | Jun 2015 | B2 |
9052533 | Pugh et al. | Jun 2015 | B2 |
9056282 | Miller et al. | Jun 2015 | B2 |
9062180 | Scales et al. | Jun 2015 | B2 |
9067811 | Bennett et al. | Jun 2015 | B1 |
9070615 | Elian et al. | Jun 2015 | B2 |
9075009 | Kim et al. | Jul 2015 | B2 |
9080267 | Batchvarova et al. | Jul 2015 | B2 |
9095823 | Fleming | Aug 2015 | B2 |
9096050 | Bedell et al. | Aug 2015 | B2 |
9096437 | Tour et al. | Aug 2015 | B2 |
9102111 | Pugh et al. | Aug 2015 | B2 |
9108158 | Yu et al. | Aug 2015 | B2 |
9110310 | Pugh et al. | Aug 2015 | B2 |
9125715 | Pugh et al. | Sep 2015 | B2 |
9134546 | Pugh et al. | Sep 2015 | B2 |
9170646 | Toner et al. | Oct 2015 | B2 |
9185486 | Pugh | Nov 2015 | B2 |
9193587 | Bennett et al. | Nov 2015 | B2 |
9195075 | Pugh et al. | Nov 2015 | B2 |
9225375 | Pugh et al. | Dec 2015 | B2 |
9388048 | Zhou et al. | Jul 2016 | B1 |
9425709 | Hayashi et al. | Aug 2016 | B2 |
9463421 | Fleming | Oct 2016 | B2 |
9475709 | Stetson et al. | Oct 2016 | B2 |
9505192 | Stoltenberg et al. | Nov 2016 | B2 |
9567224 | Bedworth | Feb 2017 | B2 |
9572918 | Bachmann et al. | Feb 2017 | B2 |
9592475 | Stoltenberg et al. | Mar 2017 | B2 |
9610546 | Sinton et al. | Apr 2017 | B2 |
20010036556 | Jen | Nov 2001 | A1 |
20010047157 | Burnett et al. | Nov 2001 | A1 |
20010055597 | Liu et al. | Dec 2001 | A1 |
20020079004 | Sato | Jun 2002 | A1 |
20020079054 | Nakatani | Jun 2002 | A1 |
20020104435 | Baker et al. | Aug 2002 | A1 |
20020115957 | Sun et al. | Aug 2002 | A1 |
20020183682 | Darvish et al. | Dec 2002 | A1 |
20020183686 | Darvish et al. | Dec 2002 | A1 |
20030052354 | Dennison | Mar 2003 | A1 |
20030134281 | Evans | Jul 2003 | A1 |
20030138777 | Evans | Jul 2003 | A1 |
20030146221 | Lauer et al. | Aug 2003 | A1 |
20030159985 | Siwy et al. | Aug 2003 | A1 |
20040061253 | Kleinmeyer et al. | Apr 2004 | A1 |
20040063097 | Evans | Apr 2004 | A1 |
20040099324 | Fraser et al. | May 2004 | A1 |
20040111968 | Day et al. | Jun 2004 | A1 |
20040112865 | McCullough et al. | Jun 2004 | A1 |
20040121488 | Chang et al. | Jun 2004 | A1 |
20040142463 | Walker et al. | Jul 2004 | A1 |
20040185730 | Lambino et al. | Sep 2004 | A1 |
20040193043 | Duchon et al. | Sep 2004 | A1 |
20040199243 | Yodfat | Oct 2004 | A1 |
20040217036 | Ginsberg et al. | Nov 2004 | A1 |
20040241214 | Kirkwood et al. | Dec 2004 | A1 |
20040251136 | Lean et al. | Dec 2004 | A1 |
20050004508 | Sun et al. | Jan 2005 | A1 |
20050004509 | Sun et al. | Jan 2005 | A1 |
20050004550 | Sun et al. | Jan 2005 | A1 |
20050010161 | Sun et al. | Jan 2005 | A1 |
20050010192 | Sun et al. | Jan 2005 | A1 |
20050015042 | Sun et al. | Jan 2005 | A1 |
20050053563 | Manissier et al. | Mar 2005 | A1 |
20050112078 | Boddupalli et al. | May 2005 | A1 |
20050126966 | Tanida et al. | Jun 2005 | A1 |
20050129633 | Lin | Jun 2005 | A1 |
20050148996 | Sun et al. | Jul 2005 | A1 |
20050170089 | Lashmore et al. | Aug 2005 | A1 |
20050189673 | Klug et al. | Sep 2005 | A1 |
20050226834 | Lambino et al. | Oct 2005 | A1 |
20050238730 | Le Fur et al. | Oct 2005 | A1 |
20060005381 | Nishi et al. | Jan 2006 | A1 |
20060036332 | Jennings | Feb 2006 | A1 |
20060073370 | Krusic et al. | Apr 2006 | A1 |
20060093885 | Krusic et al. | May 2006 | A1 |
20060121279 | Petrik | Jun 2006 | A1 |
20060151382 | Petrik | Jul 2006 | A1 |
20060166347 | Faulstich et al. | Jul 2006 | A1 |
20060180604 | Ginsberg et al. | Aug 2006 | A1 |
20060222701 | Kulkarni et al. | Oct 2006 | A1 |
20060253078 | Wu et al. | Nov 2006 | A1 |
20070004640 | Lin et al. | Jan 2007 | A1 |
20070032054 | Ramaswamy et al. | Feb 2007 | A1 |
20070056894 | Connors, Jr. | Mar 2007 | A1 |
20070060862 | Sun et al. | Mar 2007 | A1 |
20070062856 | Pahl et al. | Mar 2007 | A1 |
20070099813 | Luizzi et al. | May 2007 | A1 |
20070131646 | Donnelly et al. | Jun 2007 | A1 |
20070284279 | Doskoczynski et al. | Dec 2007 | A1 |
20080017564 | Hammond | Jan 2008 | A1 |
20080035484 | Wu et al. | Feb 2008 | A1 |
20080035541 | Franzreb et al. | Feb 2008 | A1 |
20080045877 | Levin et al. | Feb 2008 | A1 |
20080061477 | Capizzo | Mar 2008 | A1 |
20080063585 | Smalley et al. | Mar 2008 | A1 |
20080081323 | Keeley et al. | Apr 2008 | A1 |
20080081362 | Keeley et al. | Apr 2008 | A1 |
20080149561 | Chu et al. | Jun 2008 | A1 |
20080156648 | Dudziak et al. | Jul 2008 | A1 |
20080170982 | Zhang et al. | Jul 2008 | A1 |
20080185293 | Klose et al. | Aug 2008 | A1 |
20080188836 | Weber et al. | Aug 2008 | A1 |
20080190508 | Booth et al. | Aug 2008 | A1 |
20080241085 | Lin et al. | Oct 2008 | A1 |
20080268016 | Fang et al. | Oct 2008 | A1 |
20080290020 | Marand et al. | Nov 2008 | A1 |
20080290111 | Ginsberg et al. | Nov 2008 | A1 |
20090023572 | Backes et al. | Jan 2009 | A1 |
20090039019 | Raman | Feb 2009 | A1 |
20090048685 | Frigstad et al. | Feb 2009 | A1 |
20090075371 | Keeley et al. | Mar 2009 | A1 |
20090087395 | Lin et al. | Apr 2009 | A1 |
20090117335 | Iyoda et al. | May 2009 | A1 |
20090148495 | Hammer et al. | Jun 2009 | A1 |
20090176159 | Zhamu et al. | Jul 2009 | A1 |
20090222072 | Robinson et al. | Sep 2009 | A1 |
20090236295 | Braun et al. | Sep 2009 | A1 |
20090241242 | Beatty et al. | Oct 2009 | A1 |
20090283475 | Hylton et al. | Nov 2009 | A1 |
20090291270 | Zettl et al. | Nov 2009 | A1 |
20090294300 | Kanzius et al. | Dec 2009 | A1 |
20090306364 | Beer et al. | Dec 2009 | A1 |
20100000754 | Mann et al. | Jan 2010 | A1 |
20100016778 | Chattopadhyay | Jan 2010 | A1 |
20100021708 | Kong et al. | Jan 2010 | A1 |
20100024722 | Ochs et al. | Feb 2010 | A1 |
20100024838 | Ochs et al. | Feb 2010 | A1 |
20100025330 | Ratto et al. | Feb 2010 | A1 |
20100055464 | Sung | Mar 2010 | A1 |
20100059378 | Elson et al. | Mar 2010 | A1 |
20100072643 | Pugh et al. | Mar 2010 | A1 |
20100076553 | Pugh et al. | Mar 2010 | A1 |
20100105834 | Tour et al. | Apr 2010 | A1 |
20100110372 | Pugh et al. | May 2010 | A1 |
20100124564 | Martinson et al. | May 2010 | A1 |
20100127312 | Grebel et al. | May 2010 | A1 |
20100161014 | Lynch et al. | Jun 2010 | A1 |
20100167551 | Dedontney | Jul 2010 | A1 |
20100196439 | Beck et al. | Aug 2010 | A1 |
20100209515 | Chantalat et al. | Aug 2010 | A1 |
20100213079 | Willis | Aug 2010 | A1 |
20100224555 | Hoek et al. | Sep 2010 | A1 |
20100228204 | Beatty et al. | Sep 2010 | A1 |
20100233781 | Bangera et al. | Sep 2010 | A1 |
20100249273 | Scales et al. | Sep 2010 | A1 |
20100258111 | Shah et al. | Oct 2010 | A1 |
20100323177 | Ruoff et al. | Dec 2010 | A1 |
20100327847 | Leiber et al. | Dec 2010 | A1 |
20110014217 | Fahmy et al. | Jan 2011 | A1 |
20110037033 | Green et al. | Feb 2011 | A1 |
20110041519 | McAlister | Feb 2011 | A1 |
20110041687 | Diaz et al. | Feb 2011 | A1 |
20110045523 | Strano et al. | Feb 2011 | A1 |
20110054418 | Pugh et al. | Mar 2011 | A1 |
20110054576 | Robinson et al. | Mar 2011 | A1 |
20110056892 | Lancaster | Mar 2011 | A1 |
20110073563 | Chang et al. | Mar 2011 | A1 |
20110092949 | Wang | Apr 2011 | A1 |
20110100921 | Heinrich | May 2011 | A1 |
20110112484 | Carter et al. | May 2011 | A1 |
20110118655 | Fassih et al. | May 2011 | A1 |
20110120970 | Joo et al. | May 2011 | A1 |
20110124253 | Shah et al. | May 2011 | A1 |
20110139707 | Siwy et al. | Jun 2011 | A1 |
20110152795 | Aledo et al. | Jun 2011 | A1 |
20110201201 | Arnold et al. | Aug 2011 | A1 |
20110202201 | Matsubara | Aug 2011 | A1 |
20110253630 | Bakajin et al. | Oct 2011 | A1 |
20110258791 | Batchvarova et al. | Oct 2011 | A1 |
20110258796 | Batchvarova et al. | Oct 2011 | A1 |
20110262645 | Batchvarova et al. | Oct 2011 | A1 |
20110263912 | Miller et al. | Oct 2011 | A1 |
20110269920 | Min et al. | Nov 2011 | A1 |
20120031833 | Ho et al. | Feb 2012 | A1 |
20120048804 | Stetson et al. | Mar 2012 | A1 |
20120116228 | Okubo | May 2012 | A1 |
20120145548 | Sivan et al. | Jun 2012 | A1 |
20120148633 | Sun et al. | Jun 2012 | A1 |
20120162600 | Pugh et al. | Jun 2012 | A1 |
20120183738 | Zettl et al. | Jul 2012 | A1 |
20120186850 | Sugiyama et al. | Jul 2012 | A1 |
20120211367 | Vecitis | Aug 2012 | A1 |
20120218508 | Pugh et al. | Aug 2012 | A1 |
20120220053 | Lee et al. | Aug 2012 | A1 |
20120234453 | Pugh et al. | Sep 2012 | A1 |
20120234679 | Garaj et al. | Sep 2012 | A1 |
20120235277 | Pugh et al. | Sep 2012 | A1 |
20120236254 | Pugh et al. | Sep 2012 | A1 |
20120236524 | Pugh et al. | Sep 2012 | A1 |
20120241371 | Revanur et al. | Sep 2012 | A1 |
20120242953 | Pugh et al. | Sep 2012 | A1 |
20120255899 | Choi et al. | Oct 2012 | A1 |
20120267337 | Striemer et al. | Oct 2012 | A1 |
20120292245 | Saito | Nov 2012 | A1 |
20120298396 | Hong et al. | Nov 2012 | A1 |
20130015136 | Bennett et al. | Jan 2013 | A1 |
20130034760 | Otts et al. | Feb 2013 | A1 |
20130045523 | Leach et al. | Feb 2013 | A1 |
20130056367 | Martinez et al. | Mar 2013 | A1 |
20130071941 | Miller | Mar 2013 | A1 |
20130096292 | Brahmasandra et al. | Apr 2013 | A1 |
20130100436 | Jackson et al. | Apr 2013 | A1 |
20130105417 | Stetson et al. | May 2013 | A1 |
20130116541 | Gracias et al. | May 2013 | A1 |
20130131214 | Scales et al. | May 2013 | A1 |
20130135578 | Pugh et al. | May 2013 | A1 |
20130146221 | Kolmakov et al. | Jun 2013 | A1 |
20130146480 | Garaj et al. | Jun 2013 | A1 |
20130152386 | Pandojirao-S et al. | Jun 2013 | A1 |
20130174978 | Pugh et al. | Jul 2013 | A1 |
20130190476 | Lancaster et al. | Jul 2013 | A1 |
20130192460 | Miller et al. | Aug 2013 | A1 |
20130192461 | Miller et al. | Aug 2013 | A1 |
20130194540 | Pugh et al. | Aug 2013 | A1 |
20130213568 | Pugh et al. | Aug 2013 | A1 |
20130215377 | Pugh et al. | Aug 2013 | A1 |
20130215378 | Pugh et al. | Aug 2013 | A1 |
20130215380 | Pugh et al. | Aug 2013 | A1 |
20130216581 | Fahmy et al. | Aug 2013 | A1 |
20130240355 | Ho et al. | Sep 2013 | A1 |
20130240437 | Rodrigues et al. | Sep 2013 | A1 |
20130248097 | Ploss, Jr. | Sep 2013 | A1 |
20130248367 | Stetson et al. | Sep 2013 | A1 |
20130249147 | Bedworth | Sep 2013 | A1 |
20130256118 | Meller et al. | Oct 2013 | A1 |
20130256139 | Peng | Oct 2013 | A1 |
20130256154 | Peng | Oct 2013 | A1 |
20130256210 | Fleming | Oct 2013 | A1 |
20130256211 | Fleming | Oct 2013 | A1 |
20130261568 | Martinson et al. | Oct 2013 | A1 |
20130269819 | Ruby et al. | Oct 2013 | A1 |
20130270188 | Karnik | Oct 2013 | A1 |
20130273288 | Luo et al. | Oct 2013 | A1 |
20130277305 | Stetson et al. | Oct 2013 | A1 |
20130295150 | Chantalat et al. | Nov 2013 | A1 |
20130309776 | Drndic et al. | Nov 2013 | A1 |
20130317131 | Scales et al. | Nov 2013 | A1 |
20130317132 | Scales et al. | Nov 2013 | A1 |
20130317133 | Scales et al. | Nov 2013 | A1 |
20130323295 | Scales et al. | Dec 2013 | A1 |
20130338611 | Pugh et al. | Dec 2013 | A1 |
20130338744 | Frewin et al. | Dec 2013 | A1 |
20140002788 | Otts et al. | Jan 2014 | A1 |
20140005514 | Pugh et al. | Jan 2014 | A1 |
20140015160 | Kung et al. | Jan 2014 | A1 |
20140017322 | Dai et al. | Jan 2014 | A1 |
20140066958 | Priewe | Mar 2014 | A1 |
20140079936 | Russo et al. | Mar 2014 | A1 |
20140093728 | Shah et al. | Apr 2014 | A1 |
20140128891 | Astani-Matthies et al. | May 2014 | A1 |
20140141521 | Peng et al. | May 2014 | A1 |
20140151288 | Miller et al. | Jun 2014 | A1 |
20140151631 | Duesberg et al. | Jun 2014 | A1 |
20140154464 | Miller et al. | Jun 2014 | A1 |
20140170195 | Fassih et al. | Jun 2014 | A1 |
20140171541 | Scales et al. | Jun 2014 | A1 |
20140174927 | Bashir et al. | Jun 2014 | A1 |
20140190004 | Riall et al. | Jul 2014 | A1 |
20140190550 | Loh et al. | Jul 2014 | A1 |
20140190676 | Zhamu et al. | Jul 2014 | A1 |
20140192313 | Riall et al. | Jul 2014 | A1 |
20140192314 | Riall et al. | Jul 2014 | A1 |
20140199777 | Ruiz et al. | Jul 2014 | A2 |
20140209539 | El Badawi et al. | Jul 2014 | A1 |
20140212596 | Jahangiri-Famenini | Jul 2014 | A1 |
20140230653 | Yu et al. | Aug 2014 | A1 |
20140230733 | Miller | Aug 2014 | A1 |
20140231351 | Wickramasinghe et al. | Aug 2014 | A1 |
20140248621 | Collins | Sep 2014 | A1 |
20140257348 | Priewe et al. | Sep 2014 | A1 |
20140257517 | Deichmann et al. | Sep 2014 | A1 |
20140259657 | Riall et al. | Sep 2014 | A1 |
20140261999 | Stetson et al. | Sep 2014 | A1 |
20140263035 | Stoltenberg et al. | Sep 2014 | A1 |
20140263178 | Sinton et al. | Sep 2014 | A1 |
20140264977 | Pugh et al. | Sep 2014 | A1 |
20140268015 | Riall et al. | Sep 2014 | A1 |
20140268020 | Pugh et al. | Sep 2014 | A1 |
20140268021 | Pugh et al. | Sep 2014 | A1 |
20140268026 | Pugh et al. | Sep 2014 | A1 |
20140272286 | Stoltenberg et al. | Sep 2014 | A1 |
20140272522 | Pugh et al. | Sep 2014 | A1 |
20140273315 | Pugh et al. | Sep 2014 | A1 |
20140273316 | Pugh et al. | Sep 2014 | A1 |
20140276481 | Pugh et al. | Sep 2014 | A1 |
20140276999 | Harms et al. | Sep 2014 | A1 |
20140306361 | Pugh et al. | Oct 2014 | A1 |
20140308681 | Strano et al. | Oct 2014 | A1 |
20140315213 | Nagrath et al. | Oct 2014 | A1 |
20140318373 | Wood et al. | Oct 2014 | A1 |
20140322518 | Addleman et al. | Oct 2014 | A1 |
20140333892 | Pugh et al. | Nov 2014 | A1 |
20140335661 | Pugh et al. | Nov 2014 | A1 |
20140343580 | Priewe | Nov 2014 | A1 |
20140346081 | Sowden et al. | Nov 2014 | A1 |
20140349892 | Van Der Zaag et al. | Nov 2014 | A1 |
20140350372 | Pugh et al. | Nov 2014 | A1 |
20140377651 | Kwon et al. | Dec 2014 | A1 |
20140377738 | Bachmann et al. | Dec 2014 | A1 |
20150015843 | Pugh et al. | Jan 2015 | A1 |
20150017918 | Pugh et al. | Jan 2015 | A1 |
20150057762 | Harms et al. | Feb 2015 | A1 |
20150061990 | Toner et al. | Mar 2015 | A1 |
20150062533 | Toner et al. | Mar 2015 | A1 |
20150063605 | Pugh | Mar 2015 | A1 |
20150066063 | Priewe | Mar 2015 | A1 |
20150075667 | McHugh et al. | Mar 2015 | A1 |
20150077658 | Pugh et al. | Mar 2015 | A1 |
20150077659 | Pugh et al. | Mar 2015 | A1 |
20150077660 | Pugh et al. | Mar 2015 | A1 |
20150077661 | Pugh et al. | Mar 2015 | A1 |
20150077662 | Pugh et al. | Mar 2015 | A1 |
20150077663 | Pugh et al. | Mar 2015 | A1 |
20150077699 | De Sio et al. | Mar 2015 | A1 |
20150077702 | Pugh et al. | Mar 2015 | A9 |
20150079683 | Yager et al. | Mar 2015 | A1 |
20150087249 | Pugh et al. | Mar 2015 | A1 |
20150096935 | Mitra et al. | Apr 2015 | A1 |
20150098910 | Mordas et al. | Apr 2015 | A1 |
20150101931 | Garaj et al. | Apr 2015 | A1 |
20150105686 | Vasan | Apr 2015 | A1 |
20150118318 | Fahmy et al. | Apr 2015 | A1 |
20150122727 | Karnik et al. | May 2015 | A1 |
20150138454 | Pugh et al. | May 2015 | A1 |
20150142107 | Pugh et al. | May 2015 | A1 |
20150145155 | Pugh et al. | May 2015 | A1 |
20150146162 | Pugh et al. | May 2015 | A1 |
20150147474 | Batchvarova et al. | May 2015 | A1 |
20150170788 | Miller et al. | Jun 2015 | A1 |
20150174253 | Sun et al. | Jun 2015 | A1 |
20150174254 | Sun et al. | Jun 2015 | A1 |
20150182473 | Bosnyak et al. | Jul 2015 | A1 |
20150185180 | Ruhl et al. | Jul 2015 | A1 |
20150196579 | Ferrante et al. | Jul 2015 | A1 |
20150202351 | Kaplan et al. | Jul 2015 | A1 |
20150212339 | Pugh et al. | Jul 2015 | A1 |
20150217219 | Sinsabaugh et al. | Aug 2015 | A1 |
20150218210 | Stetson et al. | Aug 2015 | A1 |
20150221474 | Bedworth | Aug 2015 | A1 |
20150231557 | Miller et al. | Aug 2015 | A1 |
20150231577 | Nair et al. | Aug 2015 | A1 |
20150247178 | Mountcastle et al. | Sep 2015 | A1 |
20150258254 | Simon | Sep 2015 | A1 |
20150258498 | Simon et al. | Sep 2015 | A1 |
20150258502 | Turowski et al. | Sep 2015 | A1 |
20150258503 | Sinton | Sep 2015 | A1 |
20150258525 | Westman et al. | Sep 2015 | A1 |
20150268150 | Newkirk et al. | Sep 2015 | A1 |
20150272834 | Sun et al. | Oct 2015 | A1 |
20150272896 | Sun et al. | Oct 2015 | A1 |
20150273401 | Miller et al. | Oct 2015 | A1 |
20150309337 | Flitsch et al. | Oct 2015 | A1 |
20150321147 | Fleming et al. | Nov 2015 | A1 |
20150321149 | McGinnis | Nov 2015 | A1 |
20150323811 | Flitsch et al. | Nov 2015 | A1 |
20150336202 | Bedworth | Nov 2015 | A1 |
20150342900 | Putnins | Dec 2015 | A1 |
20150346382 | Bliven et al. | Dec 2015 | A1 |
20150351887 | Peters | Dec 2015 | A1 |
20150359742 | Fassih et al. | Dec 2015 | A1 |
20150378176 | Flitsch et al. | Dec 2015 | A1 |
20160009049 | Stoltenberg et al. | Jan 2016 | A1 |
20160038885 | Hogen-Esch et al. | Feb 2016 | A1 |
20160043384 | Zhamu et al. | Feb 2016 | A1 |
20160058932 | Stetson et al. | Mar 2016 | A1 |
20160059190 | Yoo et al. | Mar 2016 | A1 |
20160067390 | Simon et al. | Mar 2016 | A1 |
20160074814 | Park et al. | Mar 2016 | A1 |
20160074815 | Sinton | Mar 2016 | A1 |
20160272499 | Graphenea | Sep 2016 | A1 |
20160282326 | Waduge et al. | Sep 2016 | A1 |
20160284811 | Yu et al. | Sep 2016 | A1 |
20160339160 | Bedworth | Nov 2016 | A1 |
20170032962 | Graphenea | Feb 2017 | A1 |
20170037356 | Simon et al. | Feb 2017 | A1 |
20170057812 | Graphenea | Mar 2017 | A1 |
Number | Date | Country |
---|---|---|
2037988 | Jan 1900 | CA |
2411935 | Dec 2002 | CA |
1128501 | Aug 1996 | CN |
101108194 | Jan 2008 | CN |
101243544 | Aug 2008 | CN |
101428198 | May 2009 | CN |
101489653 | Jul 2009 | CN |
101996853 | Mar 2011 | CN |
102242062 | Nov 2011 | CN |
102344132 | Feb 2012 | CN |
102423272 | Apr 2012 | CN |
102592720 | Jul 2012 | CN |
101996853 | Aug 2012 | CN |
102637584 | Aug 2012 | CN |
103153441 | Jun 2013 | CN |
103182249 | Jul 2013 | CN |
103603706 | Feb 2014 | CN |
19536560 | Mar 1997 | DE |
10 2005 049 388 | Apr 2007 | DE |
0 364 628 | Apr 1990 | EP |
1 034 251 | Jan 2004 | EP |
1 777 250 | Apr 2007 | EP |
1 872 812 | Jan 2008 | EP |
2 060 286 | May 2009 | EP |
2 107 120 | Oct 2009 | EP |
2 230 511 | Sep 2010 | EP |
1 603 609 | May 2011 | EP |
2 354 272 | Aug 2011 | EP |
2 450 096 | May 2012 | EP |
2 489 520 | Aug 2012 | EP |
2 511 002 | Oct 2012 | EP |
2 586 473 | May 2013 | EP |
2 679 540 | Jan 2014 | EP |
2 937 313 | Oct 2015 | EP |
3 070 053 | Sep 2016 | EP |
3 084 398 | Oct 2016 | EP |
1 538 2430 | Mar 2017 | EP |
3 135 631 | Mar 2017 | EP |
59-102111 | Jul 1984 | JP |
10-510471 | May 1995 | JP |
7504120 | May 1995 | JP |
2001-232158 | Aug 2001 | JP |
2004-179014 | Jun 2004 | JP |
2005-126966 | May 2005 | JP |
2006-188393 | Jul 2006 | JP |
2011-168448 | Sep 2011 | JP |
2011-241479 | Dec 2011 | JP |
2004-202480 | Jul 2014 | JP |
2015-503405 | Feb 2015 | JP |
2016-175828 | Oct 2016 | JP |
1020110084110 | Jul 2011 | KR |
10-2012-0022164 | Mar 2012 | KR |
1020120022164 | Mar 2012 | KR |
1020140002570 | Jan 2014 | KR |
WO-9333901 | Mar 1993 | WO |
WO-9312859 | Aug 1993 | WO |
WO-9500231 | Jan 1995 | WO |
WO-9712664 | Apr 1997 | WO |
WO-9830501 | Jul 1998 | WO |
WO-0070012 | Nov 2000 | WO |
WO-02055539 | Jul 2002 | WO |
WO-2013115762 | Aug 2003 | WO |
WO-2004009840 | Jan 2004 | WO |
WO-2004082733 | Sep 2004 | WO |
WO-2005047857 | May 2005 | WO |
WO-2007103411 | Sep 2007 | WO |
WO 2007140252 | Dec 2007 | WO |
WO-2008008533 | Jan 2008 | WO |
WO-2009129984 | Oct 2009 | WO |
WO-2010006080 | Jan 2010 | WO |
WO-2010115904 | Oct 2010 | WO |
WO-2011019686 | Feb 2011 | WO |
WO-2011046706 | Apr 2011 | WO |
WO-2011001674 | Jun 2011 | WO |
WO-2011063458 | Jun 2011 | WO |
WO-2011075158 | Jun 2011 | WO |
WO 2011094204 | Aug 2011 | WO |
WO-2011100458 | Aug 2011 | WO |
WO-2011138689 | Nov 2011 | WO |
WO-2012006657 | Jan 2012 | WO |
WO-2012021801 | Feb 2012 | WO |
WO-2012027148 | Mar 2012 | WO |
WO-2012028695 | Mar 2012 | WO |
WO-2012030368 | Mar 2012 | WO |
WO-2012125770 | Sep 2012 | WO |
WO-2012138671 | Oct 2012 | WO |
WO-2012142852 | Oct 2012 | WO |
WO-2013016445 | Jan 2013 | WO |
WO-2013048063 | Apr 2013 | WO |
WO-2013138137 | Sep 2013 | WO |
WO 2013138698 | Sep 2013 | WO |
WO-2013151799 | Oct 2013 | WO |
WO-2013152179 | Oct 2013 | WO |
WO-2014084861 | Jun 2014 | WO |
WO-2014168629 | Oct 2014 | WO |
WO-2015030698 | Mar 2015 | WO |
WO-2015138736 | Sep 2015 | WO |
WO-2015138752 | Sep 2015 | WO |
WO-20151138771 | Sep 2015 | WO |
WO-2015197217 | Dec 2015 | WO |
WO-2016102003 | Jun 2016 | WO |
Entry |
---|
Allen et al. (Oct. 2002), “Craters on silicon surfaces created by gas cluster ion impacts,” Journal of Applied Physics, vol. 92, No. 7, pp. 3671-3678. |
AMI Applied Membranes Inc., Filmtec Nanofiltration Membrane Elements, <<appliedmembranes.com/nanofiltration—elements.htm>>, accessed Apr. 28, 2015. |
Apel (Jun. 2001), “Track etching technique in membrane technology”; Radiation Measurements, Elsevier, Amsterdam, vol. 34, No. 1-6; Jun. 1, 2001; pp. 559-566. |
Bai (Jingwei) et al. (Feb. 2010), “Graphene nanomesh”; Nature Nanotechnology; Feb. 14, 2010; whole document. |
Baker (Apr. 2004), “Membrane Technology and Applications”; Membrane Technology and Applications; Apr. 14, 2004; pp. 92-94. |
Childres et al. (Feb. 2011), “Effect of oxygen plasma etching on graphene studied using Raman spectroscopy and electronic transport measurements”; New Journal of Physics; Feb. 2011, vol. 13. |
Clochard, “Track-etched polymer membranes,” Ecole Polytechnique, <<Isi.polytechnique.fr/home/research/physics-and-chemistry-of-nano-objects/track-etched-polymer-membranes-97035.kjsp>> Accessed Jul. 30, 2015. |
Cohen-Tanugi et al. (2012), “Water Desalination across Nanoporous Graphene”, ACS Publications; MIT; 2012 dx.doi.org/10.1021/nl3012853 | Nano Lett. 2012, 12(7), pp. 3602-3608. |
Fischbein et al. (Sep. 2008), “Electron beam nanosculpting of suspended graphene sheets”; Applied Physics Letters; American Institute of Physics; vol. 93, No. II; Sep. 16, 2008. |
Galashev (Nov. 2014), “Computer study of the removal of Cu from the graphene surface using Ar clusters.” Computational Materials Science 98 (2015): 123-128. |
International Search Report and Written Opinion mailed Apr. 30, 2015, corresponding to International Patent Application No. PCT/US15/13805. |
Inui et al. (Dec. 2009), “Molecular dynamics simulations of nanopore processing in a graphene sheet by using gas cluster ion beam,” Appl Phys A (2010) 98: 787-794. |
Jiang et al. (Dec. 2009), “Porous graphene as the ultimate membrane for gas separation”; Nano Letters; America! Chemical Society, USA; Dec. 9, 2009; vol. 9, No. 12; pp. 4019-4024. |
Karan et al. (Jan. 2012), “Ultrafast Viscous Permeation of Organic Solvents Through Diamond-Like Carbon Nanosheets”; Science Magazine; vol. 33S; Jan. 27, 2012. |
Kim et al. (Mar. 2010), “Fabrication and Characterization of Large-Area, Semiconducting Nanoperforated Graphene Materials,” DOI: 10.1021/nl9032318 | Nano Lett 2010, 10 (4), pp. 1125-1131. |
Kim et al. (Sep. 2009), “The structural and electrical evolution ofgraphene by oxygen plasma induced disorder”; Nanotechnology IOP Publishing Ltd, UK; vol. 20, No. 37; Sep. 16, 2009. |
Lehtinen et al. (Feb. 2011), “Cutting and controlled modification of graphene with ion beams,” Nanotechnology 22 175306. |
Liu et al. (Jun. 2008), “Graphene Oxidation: Thickness-Dependent Etching and Strong Chemical Doping,” Nano Lett. 2008, vol. 8, No. 7, p. 1965-1970. |
Liu et al. (Mar. 2014), “Atomically Thin Molybdenum Disulfide Nanopores with High Sensitivity for DNA Translocation”; ACS Nano; vol. 8, No. 3; Mar. 25, 2014; pp. 2504-2511. |
Morse (Apr. 2010), “Scalable Synthesis of Semiconducting Nanopatterned Graphene Materials”; InterNano Resources for Nanomanufacturing; Apr. 30, 2010. |
O'Hern et al. (Mar. 2014), “Selective Ionic Transport through Tunable Subnanometer Pores in Single-Layer Graphene Membranes.” NanoLetters. DOI: 10.1021/nl404118f Nano Lett. 14, No. 3: 1234-1241. |
O'Hern et al. (Sep. 2011), “Development of process to transfer large areas of LPCVD graphene from copper foil to a porous support substrate,” Massachusetts Institute of Technology, Thesis, pp. 1-62. |
Plant et al. (Oct. 2013), “Size-dependent propagation of Au nanoclusters through few-layer graphene,” Nanoscale, DOI: 10.1039/c3nr04770a. |
Popok, Vladimir. “Cluster Ion Implantation in Graphite and Diamond: Radiation Damage and Stopping of Cluster Constituents.” Reviews on Advanced Materials Science 38(1), pp. 7-16. |
Russo et al. (Apr. 2012), “Atom-by-atom nucleation and growth of graphene nanopores,” PNAS | Apr. 17, 2012 | vol. 109 | No. 16 | 5953-5957. |
Vlassiouk et al. (Dec. 2009), “Versatile ultrathin nanoporous silicon nitride membranes”; Proceedings of the National Academy Of Sciences; National Academy of Sciences; vol. 106, No. 50; Dec. 15, 2009; pp. 21039-21044. |
Wadvalla (2012), “Boosting agriculture through seawater,” Nature Middle East, doi:10.1038/nmiddleeast.2012.92 <<natureasia.com/en/nmiddleeast/article/10.1038/nmiddleeast.2012.92?WT.mc—id=FBK—NatureMEast>> Accessed Jul. 30, 2015. |
Wikipedia, “Ion track” <<en.wikipedia.org/wiki/Ion—track>> Accessed Jul. 30, 2015. |
Zabihi et al. (Jan. 2015), “Formation of nanopore in a suspended graphene sheet with argon cluster bombardment: A molecular dynamics simulation study.” Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms 343 (2015): 48-51. |
Zan et al. (2012), “Graphene Reknits Its Holes”, Nano Lett., 2012, 12 (8), pp. 3936-3940. |
Zhang et al. (Mar. 2011), “Method for anisotropic etching of graphite or graphene”; Institute of Physics, Chinese Academy of Sciences; PEOP. Rep. China; Mar. 30, 2011. |
Zhao et al. (2012), “Effect of SiO2 substrate on the irradiation-assisted manipulation of supported graphene: a molecular dynamics study,” Nanotechnology 23 285703. |
Zhao et al. (May 2012), “Drilling Nanopores in Graphene with Clusters: A Molecular Dynamics Study,” J. Phys. Chem. C 2012, 116, 11776-11782. |
Notice of Allowance for U.S. Appl. No. 14/819,273 dated Oct. 28, 2016. |
U.S. Office Action for U.S. Appl. No. 14/193,007 dated Oct. 21, 2016. |
U.S. Office Action for U.S. Appl. No. 14/193,007 dated Dec. 21, 2015. |
U.S. Office Action for U.S. Appl. No. 14/193,007 dated Jul. 1, 2016. |
CN Office Action in Chinese Application No. 201380013988.9 dated Aug. 18, 2016 (English translation not readily available). |
U.S. Notice of Allowance in U.S. Appl. No. 14/610,770 dated Aug. 12, 2016. |
U.S. Office Action in U.S. Appl. No. 14/656,190 dated Aug. 29, 2016. |
U.S. Office Action for U.S. Appl. No. 14/656,580 dated Jun. 2, 2016. |
U.S. Office Action in U.S. Appl. No. 14/819,273 dated Jul. 6, 2016. |
U.S. Office Action for U.S. Appl. No. 14/856,198 dated Jun. 3, 2016. |
Yoon, “Simulations show how to turn graphene's defects into assets,” ScienceDaily (Oct. 4, 2016), www.sciencedaily.com/releases/2016/10/161004120428.htm. |
Zhang et al. Modern Thin-Film Technology 284-285 (Metallurgical Industry Press, 1st ed. 2009) (English translation not readily available). |
Adiga et al., “Nanoporous Materials for Biomedical Devices,” JOM 60: 26-32 (Mar. 25, 2008). |
Atmeh et al., “Albumin Aggregates: Hydrodynamic Shape and Physico-Chemical Properties,” Jordan Journal of Chemistry, 2(2): 169-182 (2007). |
Bae et al., “Roll-to-roll production of 30-inch graphene films for transparent electrodes,” Nature Nanotechnology 5: 574-578 (Jun. 20, 2010). |
Butler et al. “Progress, Challenges, and Opportunities in Two-Dimensional Materials Beyond Graphene”, Materials Review 7(4): 2898-2926 (Mar. 6, 2013). |
Chen et al., “Mechanically Strong, Electrically Conductive, and Biocompatible Graphene Paper,” Adv. Mater., 20(18): 3557-3561 (Sep. 2008) (available online Jul. 2008). |
Chhowalla et al., “The chemistry of two-dimensional layered transition metal dichalcogenide nanosheets,” Nature Chemistry 5: 263-275 (Mar. 20, 2013). |
Cohen-Tanugi, “Nanoporous graphene as a water desalination membrane,” Thesis: Ph.D., Massachusetts Institute of Technology, Department of Materials Science and Engineering (Jun. 2015). |
Colton, “Implantable biohybrid artificial organs,” Cell Transplantation 4(4): 415-436 (Jul.-Aug. 1995). |
Desai et al., “Nanoporous microsystems for islet cell replacement,” Advanced Drug Delivery Reviews 56: 1661-1673 (Jul. 23, 2004). |
Dong et al., “Growth of large-sized graphene thin-films by liquid precursor-based chemical vapor deposition under atmospheric pressure,” Carbon 49(11): 3672-3678 (May 2011). |
Fissell et al., “High-Performance Silicon Nanopore Hemofiltration Membranes,” NIH-PA Author Manuscript, PMC, (Jan. 5, 2010), also published in J. Memb. Sci. 326(1): 58-63 (Jan. 5, 2009). |
Fuertes et al., “Carbon composite membranes from Matrimid® and Kapton® polyimides for gas separation,” Microporous and Mesoporous Materials, 33: 115-125 (Dec. 1999). |
Gimi et al., “A Nanoporous, Transparent Microcontainer for Encapsulated Islet Therapy,” J. Diabetes Sci. Tech. 3(2): 1-7 (Mar. 2009). |
Hong et al., “Graphene multilayers as gates for multi-week sequential release of proteins from surfaces,” NIH-PA Author Manuscript PMC (Jun. 1, 2014), also published in ACS Nano, Jan. 24, 2012; 6(1): 81-88 (first published online Dec. 29, 2011). |
Hu et al., “Enabling graphene oxide nanosheets as water separation membranes,” Environmental Science & Technology 47(8): 3715-3723 (Mar. 14, 2013). |
International Search Report and Written Opinion in PCT/US2015/013599 dated Jul. 20, 2015. |
International Search Report and Written Opinion in PCT/US2015/018114 dated Jun. 3, 2015. |
International Search Report and Written Opinion in PCT/US2015/020246 dated Jun. 10, 2015. |
International Search Report and Written Opinion in PCT/US2015/020296 dated Jun. 17, 2015. |
International Search Report and Written Opinion in PCT/US2015/028948 dated Jul. 16, 2015. |
International Search Report and Written Opinion in PCT/US2015/029932 dated Oct. 6, 2015. |
International Search Report and Written Opinion in PCT/US2016/027607 dated Jul. 22, 2016. |
International Search Report and Written Opinion in PCT/US2016/027616 dated Jul. 22, 2016. |
International Search Report and Written Opinion in PCT/US2016/027596 dated Jul. 22, 2016. |
International Search Report and Written Opinion in PCT/US2016/027603 dated Jul. 22, 2016. |
International Search Report and Written Opinion in PCT/US2016/027610 dated Jul. 22, 2016. |
International Search Report and Written Opinion in PCT/US2016/027612 dated Jul. 22, 2016. |
International Search Report and Written Opinion in PCT/US2016/027637 dated Jun. 22, 2016. |
International Search Report in PCT/US15/20201 dated Jun. 10, 2015. |
International Search Report in PCT/US2015/048205 dated Dec. 4, 2015. |
Joshi et al., “Precise and ultrafast molecular sieving through graphene oxide membranes”, Science 343(6172): 752-754 (Feb. 14, 2014). |
Kanani et al., “Permeability—Selectivity Analysis for Ultrafiltration: Effect of Pore Geometry,” NIH-PA Author Manuscript, PMC, (Mar. 1, 2011), also published in J. Memb. Sci. 349(1-2): 405 (Mar. 1, 2010). |
Karan et al., “Ultrafast Viscous Permeation of Organic Solvents Through Diamond-Like Carbon Nanosheets,” Science 335: 444-447 (Jan. 27, 2012). |
Koh et al., “Sensitive NMR Sensors Detect Antibodies to Influenza,” NIH PA Author Manuscript PMC (Apr. 2009), also published in Angew. Chem. Int'l. Ed. Engl, 47(22): 4119-4121 (May 2008) (available online Apr. 2008). |
Koski and Cui, “The New Skinny in Two-Dimensional Nanomaterials”, ACS Nano 7(5): 3739-3743 (May 16, 2013). |
Kurapati et al., “Graphene oxide based multilayer capsules with unique permeability properties: facile encapsulation of multiple drugs,” Chemical Communication 48: 6013-6015 (Apr. 25, 2012). |
Li et al., “3D graphene oxide-polymer hydrogel: near-infrared light-triggered active scaffold for reversible cell capture and on-demand release,” Advanced Materials 25: 6737-6743 (Oct. 7, 2013). |
Marquardt et al., “Hybrid materials of platinum nanoparticles and thiol-functionalized graphene derivatives,” Carbon 66: 285-294 (Jan. 2014; first published online Sep. 12, 2013). |
Matteucci et al., “Chapter 1: Transport of gases and Vapors in Glass and Rubbery Polymers,” in Materials Science of Membranes for Gas and Vapor Separation (Yampolskii et al eds. 2006) (available online Jun. 2006). |
Mishra et al., “Functionalized Graphene Sheets for Arsenic Removal and Desalination of Sea Water,” Desalination 282: 39-45 (Nov. 1, 2011). |
Nair et al., “Unimpeded Permeation of Water Through Helium-Leak-tight Graphene-Based Membranes,” Science 335: 442-444 (Jan. 27, 2012). |
Nam et al., “Monodispersed PtCo nanoparticles on hexadecyltrimethylammonium bromide treated graphene as an effective oxygen reduction reaction catalyst for proton exchange membrane fuel cells,” Carbon 50: 3739-3747 (Aug. 2012) (available online Apr. 2012). |
Nandamuri et al., “Chemical vapor deposition of graphene films,” Nanotechnology 21(14): 1-4 (Mar. 10, 2010). |
Nayini et al., “Synthesis and characterization of functionalized carbon nanotubes with different wetting behaviors and their influence on the wetting properties of carbon nanotubes/polymethylmethacrylate coatings,” Progress in Organic Coatings, 77(6): 1007-1014 (Jun. 2014) (available online Mar. 2014). |
O'Hern et al. “Selective Molecular Transport through Intrinsic Defects in a Single Layer of CVD Graphene,” ACS Nano, 6(11): 10130-10138 (Oct. 2, 2012). |
Paul, “Creating New Types of Carbon-Based Membranes,” Science 335: 413-414 (Jan. 27, 2012). |
Schweicher et al., “Membranes to achieve immunoprotection of transplanted islets,” NIH-PA Author Manuscript, PMC, (Nov. 13, 2014), also published in Frontiers in Bioscience (Landmark Ed) 19: 49-76 (Jan. 1, 2014). |
Sint et al., “Selective Ion Passage through Functionalized Graphene Nanopores,” JACS 130: 1644816449 (Nov. 14, 2008). |
Suk et al., “Water Transport Through Ultrathin Graphene,” Journal of Physical Chemistry Letters 1(10): 1590-1594 (Apr. 30, 2010). |
Sun et al., “Growth of graphene from solid carbon sources,” Nature 468(7323): 549-552 (Nov. 25, 2010; including corrigendum in Nature 471(7336): 124 (Mar. 2011). |
Tan et al., “Beta-cell regeneration and differentiation: how close are we to the ‘holy grail’?” J. Mol. Encodrinol. 53(3): R119-R129 (Dec. 1, 2014). |
Tang et al., “Highly wrinkled cross-linked graphene oxide membranes for biological and charge-storage applications,” Small 8(3): 423-431 (Feb. 6, 2012; first published online Dec. 13, 2011). |
Xu et al., “Graphene-like Two-Dimensional Materials”, Chemical Reviews 113: 3766-3798 (Jan. 3, 2013). |
Zhao et al. “Two-Dimensional Material Membranes: An Emerging Platform for Controllable Mass Transport Applications,” Small 10(22): 4521-4542 (Sep. 10, 2014). |
Barreiro et al. “Understanding the catalyst-free transformation of amorphous carbon into graphene by current-induced annealing,” Scientific Reports, 3 (Article 1115): 1-6 (Jan. 23, 2013). |
Botari et al., “Graphene healing mechanisms: A theoretical investigation,” Carbon, 99: 302-309 (Apr. 2016) (published online Dec. 12, 2015). |
Chen et al., “Defect Scattering in Graphene,” Physical Review Letters, 102: 236805-1-236805-4 (Jun. 12, 2009). |
Chen et al., “Self-healing of defected graphene,” Applied Physics Letters, 102(10): 103107-1-103107-5 (Mar. 13, 2013). |
Cheng et al., “Ion Transport in Complex Layered Graphene-Based Membranes with Tuneable Interlayer Spacing,” Science Advances 2(2): 1501272 (Feb. 12, 2016). |
Crock et al., “Polymer Nanocomposites with Graphene-Based Hierarchical Fillers as Materials for Multifunctional Water Treatment Membranes.” Water Research 47(12): 3984-3996 (Aug. 2013; first published online Mar. 29, 2013). |
International Search Report and Written Opinion dated Jan. 13, 2017 from related PCT application PCT/US2016/027583. |
International Search Report and Written Opinion dated Jan. 13, 2017 from related PCT application PCT/US2016/027594. |
International Search Report and Written Opinion dated Jan. 13, 2017 from related PCT application PCT/US2016/027631. |
International Search Report and Written Opinion dated Jan. 9, 2017 from related PCT application PCT/US2016/027628. |
International Search Report and Written Opinion dated Jan. 9, 2017 from related PCT/US2016/027632. |
International Search Report dated Dec. 27, 2016 from related PCT application PCT/US2016/052007. |
International Search Report dated Dec. 8, 2016 from related PCT application PCT/US2016/027629. |
Kjeldsen, T., “Yeast secretory expression of insulin precursors,” Appl Microbiol Biotechnol, 54: 277-286 (May 2, 2000). |
Lin et al., “A Direct and Polymer-Free Method for Transferring Graphene Grown by Chemical Vapor Deposition to Any Substrate,” ACSNANO, 8(2): 1784-1791 (Jan. 28, 2014). |
Liu et al. “Synthesis of high-quality monolayer and bilayer graphene on copper using chemical vapor deposition,” Carbon, 49(13): 4122-4130 (Nov. 2011) (published online May 30, 2011). |
O'Hern et al., “Nanofiltration across defect-sealed nanoporous monolayer graphene,” Nano Letters, 15(5): 3254-3260 (published Apr. 27, 2015). |
U.S. Corrected Notice of Allowance in U.S. Appl. No. 13/480,569 dated May 26, 2015. |
U.S. Corrected Notice of Allowance in U.S. Appl. No. 14/819,273 dated Apr. 12, 2017. |
U.S. Corrected Notice of Allowance in U.S. Appl. No. 14/856,198 dated Mar. 1, 2017. |
U.S. Notice of Allowance in U.S. Appl. No. 13/480,569 dated Feb. 27, 2015. |
U.S. Notice of Allowance in U.S. Appl. No. 14/819,273 dated Dec. 14, 2016. |
U.S. Notice of Allowance in U.S. Appl. No. 14/856,198 dated Feb. 10, 2017. |
U.S. Office Action in U.S. Appl. No. 14/609,325 dated Feb. 16, 2017. |
U.S. Office Action in U.S. Appl. No. 13/480,569 dated Jul. 30, 2014. |
U.S. Office Action in U.S. Appl. No. 14/193,007 dated Mar. 23, 2017. |
U.S. Office Action in U.S. Appl. No. 14/656,580 dated Feb. 9, 2017. |
U.S. Office Action in U.S. Appl. No. 14/843,944 dated Jan. 6, 2017. |
U.S. Office Action in U.S. Appl. No. 14/856,471 dated Dec. 1, 2016. |
U.S. Office Action in U.S. Appl. No. 15/099,464 dated Mar. 10, 2017. |
U.S. Restriction Requirement in U.S. Appl. No. 14/193,007 dated Jul. 17, 2015. |
Wang et al., “Graphene Oxide Membranes with Tunable Permeability due to Embedded Carbon Dots.” Chemical Communications 50(86): 13089-13092 (Nov. 2014; first published online Sep. 3, 2014). |
Written Opinion dated Dec. 20, 2016 from related PCT application PCT/US2016/052010. |
Written Opinion dated Jan. 6, 2017 from related PCT application PCT/US2016/027590. |
Xu et al., “Graphene Oxide-TiO2 Composite Filtration Membranes and their Potential Application for Water Purification.” Carbon 62: 465-471 (Oct. 2013; first published online Jun. 21, 2013). |
Zhao et al., “A glucose-responsive controlled release of insulin system based on enzyme multilayers-coated mesoporous silica particles,” Chem. Commun., 47: 9459-9461 (Jun. 15, 2011). |
“Pall Water Processing Disc-Tube Filter Technology”, Pall Corporation, [retrieved on Feb. 10, 2015], retrieved from http://www.pall.com/pdfs/Fuels-and-Chemicals/Disc-Tube—Filter—Technoloqy-DT100b.pdF. |
AE Search and Examination Report for United Arab Emirates Application No. P186/13 dated Oct. 4, 2016. |
Agenor et al., “Renal tubular dysfunction in human visceral leishmaniasis (Kala-azar),” Clinical Nephrology 71(5): 492-500 (May 2009) (available online Mar. 21, 2011). |
Albert et al., “Ringer's lactate is compatible with the rapid infusion of AS-3 preserved packed red blood cells,” Can. J. Anaesth. 56(5): 352-356 (May 2009) (available online Apr. 2, 2009). |
Aluru et al. “Modeling electronics on the nanoscale.” Handbook of nanoscience, engineering and technology Goddard W, Brenner D, Lyshevski S, lafrate GJ (2002): 11-1. |
Alvarenga, “Carbon nanotube materials for aerospace wiring” Rochester Institute of Technology, 2010. |
AMI Applied Membranes Inc., Filmtec Nanofiltration Membrane Elements, appliedmembranes.com/nanofiltration—elements.htm, accessed Apr. 28, 2015. |
Aso et al., “Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin,” Diabetes 55(7): 1954-1960 (Jul 2006). |
AU Examination Report for Australian Patent Application No. 2013235234, dated Jan. 13, 2017, 4 pages. |
AU Notice of Acceptance for Australian Application No. 2011293742 dated Jan. 13, 2016. |
Axelsson et al., “Acute hyperglycemia induces rapid, reversible increases in glomerular permeability in nondiabetic rats,” Am. J. Physiol. Renal Physiol. 298(6): F1306-F1312 (Jun. 2010) (available online Mar. 17, 2010). |
Bae et al. “Roll-to-roll production of 30-inch graphene films for transparent electrodes.” Nature nanotechnology 5.8 (2010): 574-578. |
Bains et al., “Novel lectins from rhizomes of two Acorus species with mitogenic activity and inhibitory potential towards murine cancer cell lines,” Int'l Immunopharmacol. 5(9): 1470-1478 (Aug. 2005) (available online May 12, 2005). |
Baker, “Membrane Technology and Applications”, Membrane Technology and Applications; Apr. 14, 2004; pp. 92-94. |
Barreiro et al. “Transport properties of graphene in the high-current limit.” Physical review letters 103.7 (2009): 076601. |
Bazargani et al. “Low molecular weight heparin improves peritoneal ultrafiltration and blocks complement and coagulation,” Peritoneal Dialysis Int'l 25(4): 394-404 (Jul 2005-Aug 2005). |
Bazargani, “Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms,” Swedish Dental J. Supp. 171: 1-57, i (2005). |
Beppu et al., “Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: investigation on hypoglycemic action and systemic absorption dynamics of aloe components,” J. Ethnopharmacol. 103(3): 468-77 (Feb. 20, 2006) (available online Jan. 6, 2006). |
Bieri et al. “Two-dimensional Polymer Formation on Surfaces: Insight into the Roles of Precursor Mobility and Reactivity” JACS, 2010, vol. 132, pp. 16669-16676. |
Bruin et al., “Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice”, Diabetologia (2013), vol. 56: 1987-1998 (Jun. 16, 2013). |
Chu Ju, et al. “Modern Biotechnology” East China University of Technology Press, (Sep. 2007), vol. 1; pp. 306-307, ISBN 978-7-5628-2116-8. |
Clochard, “Track-etched polymer membranes,” Ecole Polytechnique,<<Isi.polytechnique.fr/home/research/physics-and-chemistry-of-nano-objects/track-etched-polymer-membranes-97035.kjsp>> Accessed Jul. 30, 2015. |
CN Notification of Grant for Chinese Application No. 201180049184.5 dated Jun. 6, 2016. |
CN Office Action for Chinese Application No. 201380014845.X dated Jul. 8, 2016. |
CN Office Action for Chinese Application No. 201380014845.X dated Sep. 2, 2015. |
CN Office Action for Chinese Application No. 201380019165.5 dated Aug. 25, 2015. |
CN Office Action for Chinese Application No. 201380073141.X dated Jun. 8, 2016. |
CN Office Action for Chinese Application No. 201380073141.X dated Mar. 21, 2017. |
CN Office Action for Chinese Application No. 201480015372.X dated Aug. 2, 2016. |
CN Office Action for Chinese Application No. 20118004918.5 dated Jun. 15, 2015. |
CN Office Action for Chinese Application No. 201180049184.5 dated Jul. 30, 2014. |
CN Office Action for Chinese Application No. 201180049184.5 dated Mar. 4, 2016. |
CN Office Action for Chinese Application No. 201380014845.X dated Dec. 23, 2016. |
CN Office Action for Chinese Application No. 201380017644.5 dated Feb. 7, 2017. |
CN Office Action for Chinese Application No. 201380017644.5 dated May 26, 2016. |
CN Office Action for Chinese Application No. 201380017644.5 dated Sep. 29, 2015. |
CN Office Action in Chinese Application No. 201380013988.9 dated Oct. 27, 2015. |
Database WPI, Week 201238, Thomson Scientific, London, GB; AN 2012-D49442. |
De Lannoy et al., “Aquatic Biofouling Prevention by Electrically Charged Nanocomposite Polymer Thin Film Membranes”, 2013 American Water Work Association membrane Technology Conference; Environmental science & technology 47.6 (2013): 2760-2768. |
Deng et al., “Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockade,” Am. J. Physiol. Renal Physiol. 299(6): F1365-F1373 (Dec. 2010) (available online Sep. 29, 2010). |
Edwards, “Large Sheets of Graphene Film Produced for Transparent Electrodes (w/ Video)”; (2010) PhysOrg.com. |
EP Office Action for European Application No. 13715529.7 dated Jun. 24, 2016. |
Fayerman, “Canadian scientists use stem cells to reverse diabetes in mice”, The Telegraph-Journal (New Brunswick), 1-2 (Jun. 29, 2012). |
Fayerman, “Diabetes reversed in mice; University of B.C. scientists use embryonic stem cells to deal with Type 1 disease”, The Vancouver Sun (British Columbia), 1-2 (Jun. 28, 2012). |
Fejes et al. “A review of the properties and CVD synthesis of coiled carbon nanotubes.” Materials 3.4 (2010): 2618-2642. |
Franzen, C. “MIT Setting Up Industrial-Scale Graphene Printing Press” Sep. 23, 2011 [retrieved from http://talkingpointsmemo.com/idealab/mit-setting-up-industrial-scale-graphene-printing-press]. |
Freedman et al., “Genetic basis of nondiabetic end-stage renal disease,” Semin. Nephrol. 30(2): 101-110 (Mar. 2010). |
Garcia-Lopez et al., “Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients,” Peritoneal Dialysis Int'l 25(2): 181-191 (Mar. 2005-Apr. 2005). |
Georgakilas et al., “Functionalization of Graphene: Covalent and Non-Covalent Approaches, Derivatives and Applications,” Chem. Rev., (2012) 112(11), pp. 6156-6214. |
Gnudi “Molecular mechanisms of proteinuria in diabetes,” Biochem. Soc. Trans. 36(5): 946-949 (Oct. 2008). |
Gotloib et al., “Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation,” Nephrol. Dialysis. Transplant. 20(Supp. 7): vii32-vii36 (Jul 2005). |
Harvey “Carbon as conductor: a pragmatic view.” Proceedings of the 61st IWCS Conference, http://www. iwcs. org/archives/56333-iwcs-2012b-1.1584632. vol. 1. 2012. |
Hashimoto et al. “Direct evidence for atomic defects in graphene layers.” Nature 430.7002 (2004): 870-873. |
He, et al. “The attachment of Fe3 O4 nanoparticles to graphene oxide by covalent bonding.” Carbon 48.11 (2010): 3139-3144. |
Hone et al. “Graphene has record-breaking strength” Physicsworld.com, Jul. 17, 2008. |
Huang et al., “Gene expression profile in circulating mononuclear cells afterexposure to ultrafine carbon particles,” Inhalation Toxicol. 22(10): 835-846 (Aug 2010). |
Humplik, et al. “Nanostructured materials for water desalination.” Nanotechnology 22.29 (2011): 292001. |
International Search Report and Written Opinion dated Jan. 5, 2012 for related International Application No. PCT/US11/47800. |
International Search Report and Written Opinion dated Mar. 12, 2014 for International Application No. PCT/US2013/074942. |
International Search Report and Written Opinion for International Application No. PCT/US2011/047800 dated Jan. 5, 2012. |
International Search Report and Written Opinion for PCT Application No. PCT/US2014/023027 dated Jun. 26, 2014. |
International Search Report and Written Opinion in International Application No. PCT/US2013/030344 dated Jun. 19, 2013. |
International Search Report and Written Opinion in International Application No. PCT/US2013/033035 dated Jun. 28, 2013. |
International Search Report and Written Opinion in International Application No. PCT/US2013/033400, dated Jun. 28, 2013. |
International Search Report and Written Opinion in International Application No. PCT/US2013/033403 dated Jun. 28, 2013. |
International Search Report and Written Opinion in PCT/US2014/041766, dated Sep. 30, 2014. |
International Search Report and Written Opinion dated Jun. 5, 2014 in International Application No. PCT/US2014/021677. |
International Search Report and Written Opinion dated Jun. 6, 2014 in International Application No. PCT/US2014/023043. |
International Search Report and Written Opinion dated Dec. 16, 2014, for International Application No. PCT/US2014/051011. |
International Search Report and Written Opinion dated Jun. 19, 2015, in International Application No. PCT/US2015/020287. |
Inui et al. “Molecular dynamics simulations of nanopore processing in a graphene sheet by using gas cluster ion beam.” Applied Physics A: Materials Science & Processing 98.4 (2010): 787-794. |
Israelachvili, “Intermolecular and Surface Forces,” 3rd ed., Chap.7.1, Sizes of Atoms, Molecules, and Ions, 2011, 1 page. |
Jiao et al., “Castration differentially alters basal and leucine-stimulated tissue protein synthesis in skeletal muscle and adipose tissue,” Am. J. Physiol. Endocrinol. Metab. 297(5): E1222-1232 (Nov. 2009) (available online Sep. 15, 2009). |
JP Office Action in Japanese Application No. 2015-501729 dated Dec. 9, 2016 (English translation). |
JP Office Action in Japanese Application No. 2015-501867 dated Oct. 11, 2016. |
JP Office Action in Japanese Application No. 2015-503405 dated Nov. 14, 2016. |
JP Office Action in Japanese Application No. 2015-503406 dated Dec. 6, 2016. |
Kang et al., “Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats,” Nephrol. Dialysis Transplant. 24(1): 73-84 (Jan. 2009). |
Kar et al., “Effect of glycation of hemoglobin on its interaction with trifluoperazine,” Protein J. 25(3): 202-211 (Apr. 2006) (available online Jun. 6, 2006). |
Kawamoto et al., “Serum high molecular weight adiponectin is associated with mild renal dysfunction in Japanese adults,” J. Atherosclerosis Thrombosis 17(11): 1141-1148 (Nov. 27, 2011). |
Khun et al. “From Microporous Regular Frameworks to Mesoporous Materials with Ultrahigh Surface Area: Dynamic reorganization of Porous Polvmer Networks” JACS, 2008, vol. 130, pp. 13333-13337. |
Krupka et al., “Measurements of the Sheet Resistance and Conductivity of Thin Epitaxial Graphene and SiC Films” Applied Physics Letters 96, 082101-I; Feb. 23, 2010. |
Kumar et al., “Modulation of alpha-crystallin chaperone activity in diabetic rat lens by curcumin,” Molecular Vision 11: 561-568 (Jul 26, 2005). |
Lathuiliere et al., “Encapsulated Cellular Implants for Recombinant Protein Delivery and Therapeutic Modulation of the Immune System,” Journal of Applied Physics, Int. J. Mol. Sci., 16: 10578-10600 (May 8, 2015). |
Lee, et al. “Measurement of the elastic properties and intrinsic strength of monolayer graphene.” science 321.5887 (2008): 385-388. |
Lucchese et al. “Quantifying ion-induced defects and Raman relaxation length in graphene.” Carbon 48.5 (2010): 1592-1597. |
Macleod et al. “Supramolecular Orderinng in Oligothiophene-Fullerene Monolayers” JAGS, 2009, vol. 131, pp. 16844-16850. |
Mattevi et al. “A review of chemical vapour deposition of graphene on copper.” Journal of Materials Chemistry 21.10 (2011): 3324-3334. |
Miao et al. “Chemical vapor deposition of grapheme” INTECH Open Access Publisher, 2011. |
MIT/MTL Center for Graphene Devices and 2D Systems, retrieved from: http://www-mtl.mit.edu/wpmu/graphene/ [retrieved from Aug. 21, 2014 archive]. |
MIT/MTL Center for Graphene Devices and 2D Systems, retrieved from: http://www-mtl.mit.edu/wpmu/graphene/ [retrieved from Mar. 4, 2015 archive]. |
Nezlin, “Circulating non-immune IgG complexes in health and disease,” Immunol. Lett. 122(2); 141144 (Feb. 21, 2009) (available online Feb. 2, 2009). |
Norata et al., “Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status,” Nutr. Metab. Cardiovasc. Dis. 20(1): 56-63 (Jan. 2010) (available online Apr. 9, 2009). |
Ogawa et al., “Exosome-like vesicles in Gloydius blomhoffii blomhoffii venom,” Toxicon 51(6): 984-993 (May 2008) (available online Feb. 19, 2008). |
Oki et al., “Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone,” J. Neurosurg. 110(2): 369-73 (Feb. 2009). |
Osorio et al., “Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats,” Diabetes Res. Clin. Pract. 86(3): e46-e49 (Dec. 2009) (available online Oct. 2, 2009). |
Osorio et al., “Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats,” J. Nephrol. 23(5): 541-546 (Sep.-Oct. 2010). |
Padidela et al., “Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period,” Eur. J. Endocrinol. 160(1): 53-58 (Jan. 2009) (available online Oct. 24, 2008). |
Plant et al. “Size-dependent propagation of Au nanoclusters through few-layer grapheme,” The Royal Society of Chemistry 2013, Nanoscale. |
Pollard, “Growing Graphene via Chemical Vapor” Department of Physics, Pomona College; May 2, 2011. |
Rezania et al., “Enrichment of Human Embryonic Stem Cell-Derived NKX6.1-Expressing Pancreatic Progenitor Cells Accelerates the Maturation of Insulin-Secreting Cells in Vivo”, Stem Cells Regenerative Medicine, vol. 31: 2432-2442 (Jul. 29, 2013). |
Rezania et al., “Maturation of Human Embryonic Stem Cell-Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice”, Diabetes Journal, vol. 61: 2016-2029 (Aug. 1, 2012). |
Ribeiro et al., “Binary Mutual Diffusion Coefficients of Aqueous Solutions of Sucrose, Lactose, Glucose, and Fructose in the Temperature Range from (298.15 to 328.15) K,” J. Chem. Eng. Data 51(5): 1836-1840 (Sep. 2006) (available online Jul. 20, 2006). |
Rippe et al., “Size and charge selectivity of the glomerular filter in early experimental diabetes in rats,” Am. J. Physiol. Renal Physiol. 293(5): F1533-F1538 (Nov. 2007)(available online Aug. 15, 2007). |
SA Final Rejection for Saudi Arabia Application No. 113340400 dated Jan. 28, 2016. |
SA First Examination Report for Saudi Arabia Application No. 113340401 dated Apr. 28, 2015. |
SA First Examination Report for Saudi Arabia Application No. 113340424 dated May 10, 2015. |
SA First Examination Report for Saudi Arabia Application No. 113340426 dated May 12, 2015. |
SA First Examination Report in Saudi Arabia Application No. 113340400 dated Apr. 13, 2015. |
SA Second Examination Report for Saudi Arabia Application No. 113340400 dated Aug. 11, 2015. |
Sethna et al., “Serum adiponectin levels and ambulatory blood pressure monitoring in pediatric renal transplant recipients,” Transplantation 88(8): 1030-1037 (Oct 27, 2009). |
Sullivan et al., “Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats,” Physiol. Genom. 23(2): 192-205 (Oct. 17, 2005) (available online Aug. 23, 2005). |
Swett et al, “Imagining and Sculpting Graphene on the atomic scale” Oak Ridge National Laboratory's (ORNL) Center for Nanophase Materials Sciences (CNMS) Biannual Review. 1 page. |
Swett et al, “Supersonic Nanoparticle Interaction with Suspended CVD Graphene”, Microsc. Microanal. 22 (Suppl 3): 1670-1671 (Jul. 25, 2016). |
Takata et al., “Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes,” Hypertension 51. 2 (Feb 2008): 534-9. |
Tamborlane et al., “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes” N Engl J Med 359;14: 1464-1476. |
Tanugi et al., “Nanoporous Graphene Could Outperform Best Commercial Water Desalination Techniques,” ; ACS 2012; Jun. 25, 2012; Weftec 2012; Sep. 29-Oct. 3. |
Totani et al. “Gluten binds cytotoxic compounds generated in heated frying oil.” Journal of oleo science 57.12 (2008): 683-690. |
Tsukamoto et al. “Purification, characterization and biological activities of a garlic oliqosaccharide,” Journal of UOEH 30. 2 (Jun. 1, 2008): 147-57. |
TW Office Action in Taiwanese Application No. 102146079 dated Apr. 14, 2017. (with English translation). |
TW Search Report in Taiwanese Application No. 102146079 dated Apr. 14, 2017. |
Umea Universitet “Graphene nanoscrolls are formed by decoration of magnetic nanoparticles.” ScienceDaily. Aug. 15, 2013. https://www.sciencedaily.com/releases/2013/08/130815084402.htm. |
U.S. Notice of Allowance for U.S. Appl. No. 12/868,150 dated Sep. 25, 2012. |
U.S. Notice of Allowance for U.S. Appl. No. 13/548,539 dated Aug. 18, 2015. |
U.S. Notice of Allowance for U.S. Appl. No. 13/548,539 dated Jul. 23, 2015. |
U.S. Notice of Allowance for U.S. Appl. No. 13/719,579 dated May 20 ,2016. |
U.S. Notice of Allowance for U.S. Appl. No. 13/795,276 dated Oct. 7, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 13/802,896 dated Apr. 1, 2015. |
U.S. Notice of Allowance for U.S. Appl. No. 13/803,958 dated Aug. 29, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 13/803,958 dated Jun. 2, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 13/803,958 dated Sep. 12, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 13/804,085 dated Jan. 15, 2015. |
U.S. Notice of Allowance for U.S. Appl. No. 13/804,085 dated Mar. 12, 2015. |
U.S. Notice of Allowance for U.S. Appl. No. 13/923,503 dated Oct. 14, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 13/923,503 dated Oct. 5, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 14/200,195 dated Jul. 5, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 14/200,530 dated Aug. 1, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 14/203,655 dated Dec. 9, 2016. |
U.S. Notice of Allowance in U.S. Appl. No. 12/868,150 dated Sep. 25, 2012. |
U.S. Notice of Allowance in U.S. Appl. No. 13/803,958 dated Aug. 29, 2016. |
U.S. Notice of Allowance in U.S. Appl. No. 13/803,958 dated Sep. 12, 2016. |
U.S. Notice of Allowance in U.S. Appl. No. 14/656,580 dated May 8, 2017. |
U.S. Notice of Allowance in U.S. Appl. No. 13/795,276 dated Jan. 19, 2017. |
U.S. Office Action for U.S. Appl. No. 13/548,539 dated Feb. 6, 2015. |
U.S. Office Action for U.S. Appl. No. 13/719,579 dated Jul. 8, 2015. |
U.S. Office Action for U.S. Appl. No. 13/719,579 dated May 4, 2016. |
U.S. Office Action for U.S. Appl. No. 13/795,276 dated Apr. 22, 2016. |
U.S. Office Action for U.S. Appl. No. 13/795,276 dated Oct. 6, 2015. |
U.S. Office Action for U.S. Appl. No. 13/802,896 dated Sep. 24, 2014. |
U.S. Office Action for U.S. Appl. No. 13/803,958 dated Aug. 11, 2014. |
U.S. Office Action for U.S. Appl. No. 13/803,958 dated May 28, 2015. |
U.S. Office Action for U.S. Appl. No. 13/803,958 dated Nov. 18, 2015. |
U.S. Office Action for U.S. Appl. No. 13/923,503 dated Mar. 22, 2016. |
U.S. Office Action for U.S. Appl. No. 14/031,300 dated Jan. 20, 2016. |
U.S. Office Action for U.S. Appl. No. 14/031,300 dated Jul. 7, 2015. |
U.S. Office Action for U.S. Appl. No. 14/200,195 dated Mar. 21, 2016. |
U.S. Office Action for U.S. Appl. No. 14/200,195 dated Nov. 4, 2015. |
U.S. Office Action for U.S. Appl. No. 14/200,530 dated Feb. 29, 2016. |
U.S. Office Action for U.S. Appl. No. 14/203,655 dated Aug. 10, 2016. |
U.S. Office Action for U.S. Appl. No. 14/656,190 dated May 18, 2017. |
U.S. Office Action for U.S. Appl. No. 14/858,741 dated Dec. 1, 2016. |
U.S. Office Action for U.S. Appl. No. 15/289,944 dated Feb. 9, 2017. |
U.S. Office Action for U.S. Appl. No. 15/336,545 dated Dec. 19, 2016. |
U.S. Office Action in U.S. Appl. No. 14/193,007 dated Apr. 24, 2017. |
U.S. Office Action in U.S. Appl. No. 14/656,617 dated Apr. 4, 2017. |
U.S. Office Action on U.S. Appl. No. 14/656,335 dated Apr., 25 2017. |
U.S. Office Action on U.S. Appl. No. 15/332,982 dated Jan. 30, 2017. |
Vallon,“Micropuncturing the nephron,” Pflugers Archiv : European journal of physiology 458. 1 (May 2009): 189-201. |
Van Der Zande et al. “Large-scale arrays of single-layer graphene resonators.” Nano letters 10.12 (2010): 4869-4873. |
Verdonck, P., “Plasma Etching”, in Oficina de Microfabricao: Projeto e Construcao de Ci's MOS, Swart, J.W., Ed., Campinas (Sao Paulo, Brazil): Unicamp, 2006, ch. 10, p. 9. |
Vlassiouk et al. “Large scale atmospheric pressure chemical vapor deposition of graphene.” Carbon 54 (2013): 58-67. |
Vriens et al. “Methodological considerations in quantification of oncological FDG PET studies.” European journal of nuclear medicine and molecular imaging 37.7 (2010): 1408-1425. |
Wang et al., “Direct Observation of a Long-Lived Single-Atom Catalyst Chiseling Atomic Structures in Graphene,” Nano Lett., 2014, pp. A-F. |
Wang et al., “Porous Nanocarbons: Molecular Filtration and Electronics,” Advances in Graphene Science, Edited by Mahmood Aliofkhazraei, (2013) ISBN 978-953-51/1182-5, Publisher: InTech; Chapter 6, pp. 119-160. |
Wang et al.,“What is the role of the second ”structural “ NADP+-binding site in human glucose 6-phosphate dehydrogenase?,”Protein science a publication of the Protein Society 17. 8 (Aug 2008): 1403-11. |
Wei et al., “Synthesis of N-doped graphene by chemical vapor deposition and its electrical properties”, Nano Lett. 2009 9 1752-58. |
Xiaogan Liang et al., Formation of Bandgap and Subbands in Graphene Nanomeshes with Sub-10nm Ribbon Width Fabricated via Nanoimprint Lithography., Nano Letters, Jun. 11, 2010, pp. 2454-2460. |
Xie et al., “Fractionation and characterization of biologically-active polysaccharides from Artemisia tripartite,” Phytochemistry 69. 6 (Apr 2008): 1359-71. |
Xie, et al. “Controlled fabrication of high-quality carbon nanoscrolls from monolayer graphene.” Nano letters 9.7 (2009): 2565-2570. |
Yagil et al. “Nonproteinuric diabetes-associated nephropathy in the Cohen rat model of type 2 diabetes” Diabetes 54. 5 (May 2005): 1487-96. |
Zan et al. “Interaction of Metals with Suspended Graphene Observed by Transmission Electron Microscopy”, J. Phys. Chem. Lett. 2012, 3, 953-958. |
Zhang et al. “Effect of chemical oxidation on the structure of single- walled carbon nanotubes”, J. Phys. Chem., 2003, B 107 3712-8. |
Zhang et al. “Method for anisotropic etching of graphite or graphene” Institute of Physics, Chinese Academy of Sciences; PEOP. Rep. China; Mar. 30, 2011. |
Zhang et al. “Production of Graphene Sheets by Direct Dispersion with Aromatic Healing Agents”, Small 2010, x, No. x, 1-8. |
Zhang et al. “Isolation and activity of an alpha-amylase inhibitor from white kidney beans,” Yao xue xue bao =Acta pharmaceutica Sinica 42. 12 (Dec 2007): 1282-7. |
Zhao, et al. “Efficient preparation of large-area graphene oxide sheets for transparent conductive films.” ACS nano 4.9 (2010): 5245-5252. |
Zhou, K., et al., “One-pot preparation of graphene/Fe304 composites by a solvothermal reaction,” New J. Chem., 2010, 34, 2950. |
Zhu et al. “Carbon nanotubes in biomedicine and biosensing.” Carbon nanotubes-Growth and Applications. InTech, (2011) Chapter 6: pp. 135-162. Available from: https://www.intechopen.com/books/carbon-nanotubes-growth-and-applications/carbon-nanotubes-in-biomedicine-and-biosensing. |
Ziegelmeier et al. “Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis,” Metabolism: clinical and experimental 57. 10 (Oct. 2008): 1414-21. |
Zirk et al. “A refractometry-based glucose analysis of body fluids,” Medical engineering & physics 29. 4 (May 2007): 449-58. |
Zyga “Nanoporous Graphene Could Outperform Best Commercial Water Desalination Techniques,” Phys.org. http://www.phys.org/pdf259579929.pdf. [Last Accessed Dec. 3, 2014]. |
AU Examination Report for Australian Patent Application No. 2013363283, dated Jun. 20, 2017, 4 pages. |
Daniel et al. “Implantable Diagnostic Device for Cancer Monitoring.” Biosens Bioelectricon. 24(11): 3252-3257 (Jul. 15, 2009). |
International Search Report and Written Opinion dated Jul. 5, 2017 from related PCT application PCT/US2017/024147. |
JP Office Action in Japanese Application No. 2015-501729 dated Jun. 20, 2017 (English translation). |
Kang et al., “Efficient Transfer of Large-Area Graphene Films onto Rigid Substrates by Hot Pressing,” American Chemical Society Nano, 6(6): 5360-5365(May 28, 2012). |
Nafea, et al. “Immunoisolating semi-permeable membranes for cell encapsulation: focus on hydrogels.” J Control Release. 154(2): 110-122 (Sep. 5, 2011). |
Ohgawara et al. “Assessment of pore size of semipermeable membrane for immunoisolation on xenoimplatntation of pancreatic B cells using a diffusion chamber.” Transplant Proc. (6): 3319-3320. 1995. |
Rafael et al. “Cell Transplantation and Immunoisolation: Studies on a macroencapsultaion device.” From the Departments of Transplantation Pathology: Stockholm, Sweden (1999). |
Sanchez, et al. “Biological Interactions of Graphene-Family Nanomaterials—An Interdisciplinary Review.” Chem Res Toxicol. 25(1): 15-34 (Jan. 13, 2012). |
U.S. Notice of Allowance in U.S. Appl. No. 14/819,273 dated Jun. 9, 2017. |
U.S. Notice of Allowance in U.S. Appl. No. 15/099,464 dated Jun. 16, 2017. |
U.S. Office Action for U.S. Appl. No. 14/656,657 dated Jul. 7, 2017. |
U.S. Office Action for U.S. Appl. No. 14/686,452 dated Jun. 9, 2017. |
U.S. Office Action for U.S. Appl. No. 14/843,944 dated Jun. 23, 2017. |
U.S. Office Action for U.S. Appl. No. 14/856,471 dated May 31, 2017. |
U.S. Office Action for U.S. Appl. No. 15/453,441 dated Jun. 5, 2017. |
CN Office Action in Chinese Application No. 201580006829.5 dated Aug. 1, 2017. (English translation) (8 pages). |
EP Office Action for European Application No. 15743307.9 dated Aug. 8, 2017. (17 pages). |
European Search Report dated Aug. 28, 2017 from related EP application 15743750.0. (7 pages). |
International Search Report and Written Opinion dated Aug. 14, 2017 from related PCT application PCT/US2017/031537. (12 pages). |
Jiang, L. et al., Design of advanced porous grapheme materials: from grapheme nanomesh to 3D architectures. Nanoscale, Oct. 16, 2013, vol. 6, pp. 1922-1945. |
JP Office Action in Japanese Application No. 2015-503405 dated Jun. 28, 2017. (English translation) (6 pages). |
JP Office Action in Japanese Application No. 2015-549508 dated Jun. 27, 2017. (English translation) (7 pages). |
Li, R.H. “Materials for immunoisolated cell transplantation”. Adv. Drug Deliv. Rev. 33, 87-109 (1998). (23 pages). |
Schweitzer, Handbook of Separation Techniques for Chemical Engineers, 1979, McGraw-Hill Book Company, pp. 2-5-2-8. |
Search Report and Written Opinion dated Aug. 14, 2017 for Singapore Application No. 11201606287V. (10 pages). |
Search Report and Written Opinion dated Aug. 22, 2017 for Singapore Application No. 11201607584P. (7 pages). |
Sears et al., “Recent Developments in Carbon Nanotube Membranes for Water Purification and Gas Separation” Materials, vol. 3 (Jan. 4, 2010), pp. 127-149. |
U.S. Notice of Allowance in U.S. Appl. No. 14/193,007 dated Sep. 6, 2017. (9 pages). |
U.S. Notice of Allowance in U.S. Appl. No. 14/656,580 dated Sep. 5, 2017. (8 pages). |
U.S. Office Action for U.S. Appl. No. 14/609,325 dated Aug. 25, 2017. (7 pages). |
U.S. Office Action for U.S. Appl. No. 15/099,193 dated Jul. 19, 2017. (13 pages). |
U.S. Office Action for U.S. Appl. No. 15/289,944 dated Jul. 13, 2017. (18 pages). |
U.S. Office Action for U.S Appl. No. 15/332,982 dated Aug. 18, 2017. (9 pages). |
Number | Date | Country | |
---|---|---|---|
20150221474 A1 | Aug 2015 | US |
Number | Date | Country | |
---|---|---|---|
61934530 | Jan 2014 | US |